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ABSTRACT 
 
Regina Irene Rutledge: Health Care System Characteristics Associated with Postpartum 
Contraceptive Utilization, Birth Spacing and Short Interpregnancy Intervals Among Privately 
Insured Women in North Carolina 
(Under the direction of Marisa Domino) 
 
Objective: To determine if provider characteristics or rural geography affect the timing of 
postpartum contraceptive, method of postpartum contraceptive, or incidence of short 
interpregnancy intervals among privately insured women in North Carolina.  
Methods: Using administrative claims data from a large, private insurer, we used two-stage 
residual inclusion and logit modeling to determine when a woman began a contraceptive, the 
likelihood that the contraceptive she began was a long-acting reversible contraceptive, and how 
these behaviors affected the probability of a subsequent live birth within 27 months of delivery. 
Our key independent variables were whether a woman received maternity care from a provider 
affiliated with an obstetrics/gynecology residency program, the provider’s specialty, and whether 
or not a woman lived in a rural area.  
Results: Receiving maternity care from a provider affiliated with an OB/GYN residency 
program was slightly negatively associated with contraceptive initiation within 3, 6 and 12 
months postpartum and had no effect on a woman’s probability of using a long-acting reversible 
method or having a subsequent short interpregnancy interval. Provider specialty did not have an 
affect on a woman’s timing of contraceptive initiation nor the probability of having a short 
interpregnancy interval. Living in a rural area had no effect on timing to postpartum 
	   iv 
contraceptive, type of postpartum contraceptive or probability of having a short interpregnancy 
interval to subsequent live birth.  
Conclusions: While we hypothesized OB/GYN providers and providers associated with an 
OB/GYN residency program would increase the probability of a woman initiating contraceptives 
within 12 months and use LARC more often than other providers, our findings did not support 
this. Among women with consistent insurance coverage during the postpartum period, short 
interpregnancy intervals were common. Controlling for characteristics associated with her 
provider, the facility where she received care, and the demographics of the area in which she 
lives, the strongest predictor of whether a woman would have a short birth interval is the type of 
contraceptive she uses in the postpartum period.  Women using a long-acting method versus a 
short-acting method were significantly less likely to have a short interpregnancy interval to their 
next birth.  
Key words: contraceptive, postpartum contraception, long-acting reversible contraceptives, 
interpregnancy intervals, birth spacing 
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CHAPTER 1: INTRODUCTION 	  
Specific Aims 
 Modern contraceptives have led to a dramatic reduction in unintended pregnancies, teen 
birth rates, and poor infant outcomes since their introduction (1). Despite highly effective 
contraceptive interventions, half of all births in the United States are unintended and almost half 
of these are unwanted(2). Postpartum contraceptive initiation is a critical component of family 
planning and healthy birth spacing. However, in a recent study in California among women with 
contraceptive coverage, only 41% of women had a contraceptive claim within 90 days 
postpartum(3). Short birth intervals are associated with numerous poor outcomes for both 
women and infants(4). While there are multiple definitions of short birth spacing, this study will 
use the most common indicator of any higher order pregnancy that is conceived within 18 
months of the end of a previous pregnancy. The Centers for Disease Control and Prevention 
identified the reduction of short interpregnancy birth intervals as a priority area by proposing a 
national reduction of 10% as a Healthy People 2020 objective(5). Prior studies have investigated 
the relationship between maternal characteristics, postpartum contraceptive practices and short 
birth intervals but little evidence exists regarding the relationship between these factors and 
health system characteristics.  
 The objective of this dissertation is to examine the relationship between perinatal health 
care setting characteristics and postpartum contraceptive initiation, short interpregnancy intervals 
among privately insured women in North Carolina.  My long-term goal is to identify the enabling 
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factors and barriers of health systems that affect women’s timely initiation of postpartum 
contraceptive services. These findings will be used to develop institutional and health insurance 
policy revisions that could lead to reduced unintended pregnancies, short interpregnancy 
intervals,  premature and low birth weight among women and children in North Carolina. I 
hypothesize that women who receive perinatal care in an urban setting or in a setting with a 
residency program in obstetrics and gynecology will be more likely to initiate contraceptives 
within 12 weeks of delivery. These women will also be more likely to initiate long-acting 
reversible contraceptives (LARC) rather than short-acting reversible contraceptives (SARC) and 
subsequently less likely to experience short interpregnancy intervals. The amount of insurance 
copayment for LARC insertion will be associated with any initiation. Rapid repeat pregnancies 
will have higher direct healthcare expenditures compared with adequately spaced births. I will 
use propensity score matching as well as an instrumental variable to address selection bias of 
both provider choice as well as contraceptive choice. The rationale of this study is to provide 
evidence to support revisions to existing institutional and insurance policies that may hinder the 
timely initiation of postpartum contraceptives. 
 
Aim 1: Determine if perinatal health setting characteristics are associated with the timeliness 
and method of postpartum contraception initiation. 
Hypothesis 1.1: Women who receive perinatal care in an urban setting or at within a setting that 
has an OB/GYN residency program are more likely to initiate any modern contraception within 
12 weeks of delivery.  
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Hypothesis 1.2: Among women who initiate any contraceptive, women receive perinatal care in 
an urban setting or within a setting that has an OB/GYN residency program are more likely to 
initiate a long-acting reversible contraceptive. 
This aim will use instrumental variables, 2SRI logistic regression analysis and nested 
multinomial logistic regression.  
Aim 2: Assess if timely initiation and method of postpartum contraception are associated with 
timing of subsequent pregnancy and rate of short interpregnancy interval. 
Hypothesis 2.1: Women who do not initiate contraceptives within 12 weeks of delivery are more 
likely to have a short interpregnancy interval compared with women who initiate any 
contraceptive. 
Hypothesis 2.2. Among women who initiate any contraceptive within 12 weeks, those who 
initiate a SARC are more likely to have a short interpregnancy interval compared with women 
who initiate a LARC.  
This aim will use instrumental variables, 2SRI logistic regression to measure incidence and 
timing of rapid repeat pregnancies.   
  
Significance 
This study will provide stakeholders with contemporary evidence that can be applied to 
policies and practices targeting improvements in family planning service provision and health 
outcomes while reducing healthcare expenditures. It will provide evidence describing the 
relationship between women, the settings in which they receive perinatal, postpartum 
contraceptive initiation practices and risk of short interpregnancy interval.  Finally, it will use the 
characteristics, outcomes and costs of a real cohort of women to generate a simulation model to 
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demonstrate that a private insurance company can reduce poor health outcomes as well as costs 
to both the company and its members by increasing the proportion of women receiving both 
timely and long-acting postpartum contraceptive.  
 
North Carolina’s pregnancy related outcomes are often worse than the national average 
and show marked disparities across geographic regions. Many of the key indicators of 
pregnancy outcome are recorded by offices of vital statistics at the county, state and national 
level via certificates of live birth and fetal death certificates. The US Standard Birth Certificate 
includes demographic information on the mother and father of the child (a third partner can be 
identified for same-sex couples in some states) including place of residence, nativity, education, 
insurance coverage, maternal risk factors such as obesity and smoking, previous pregnancy 
outcomes, parity, gravidity. Labor and delivery indicators include location of delivery, attendant 
information, and, indications of facility transfer, indications of labor complications, and type of 
delivery. Birth outcomes information includes gestational age, birth weight, NICU admission, 
respiratory complications, congenital anomalies and proposed breastfeeding practices.(6) North 
Carolina has higher rates of very low birthweight, low birthweight, smoking during pregnancy, 
and infant mortality as well as lower maternal educational attainment as compared with the 
nation (Figure 1.1).  
In North Carolina, women who live in micropolitan and rural areas are more likely to 
experience preterm birth and have low birthweight infants as compared with women in 
metropolitan areas (Figure 1.2) Pregnant women in non-metropolitan counties are also more like 
to smoke during pregnancy, be overweight or obese preconceptively, have a history of preterm 
birth and be grandmultiparous (have at least five previous live births) (Figure 1.2)(7). 
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While birth certificates offer a wealth of information about the facts regarding births, they 
do not provide critical information such as the intention or wantedness of pregnancies. Birth 
certificates do not provide information about the preconceptive contraceptive practices or assess 
if a potential contraceptive failure occurred. However, in 1987 the Centers for Disease Control 
and Prevention launched PRAMS, the Pregnancy Risk Assessment Monitoring System, to collect 
information systematically about aspects of pregnancy not typically included in standardized 
birth certificates or health records. PRAMS is conducted at the state level; state participation is 
not mandatory.  The states that choose to participate select a sample the birth records for a year 
as potential participants. Some populations are oversampled so that higher risk groups are 
appropriate represented. Topics women are surveyed on are demographics, delivery 
characteristics, influenza vaccination practice, family planning, maternal health history and 
experiences, prenatal care and insurance coverage(8).  
PRAMS remains the most generalizable and comparable dataset for comparing 
pregnancy intention, wantedness, and postpartum contraceptive initiation. Among postpartum 
women of North Carolina surveyed in 2008, they were more likely to to report their last 
pregnancy to be unintended and unwanted pregnancy yet also were not using contraception 
despite not wanting to become pregnant again. Additionally, North Carolina women who were 
not using contraceptives in the postpartum period were more likely than the US sample to report 
their reason for not using contraceptives were already being pregnant (indicating a short 
interpregnancy interval) or not being able to afford contraceptives. While the US PRAMS 
sample indicated 5.1% of women did not use postpartum contraceptives because they could not 
afford them in 2008, more than 12% of North Carolina women sampled they could not afford 
them(9).  
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Short birth intervals are associated with poor health outcomes and higher costs to 
the health care system.  The evidence regarding the relationship between short birth intervals 
and poor maternal and child health outcomes is expansive.  The most commonly cited poor 
health outcomes for women associated with short birth spacing are eclampsia (10,11), anemia 
(12–14), uterine rupture (15–17), third trimester bleeding (12), premature membrane rupture 
(10,18), puerperal endometriosis (12,18),  placental previa (19), and maternal death (12,20,21). 
Conde and colleagues conducted one of the largest cross-sectional studies of interpregnancy 
spacing and maternal health outcomes with 456,889 parous women between 1985 and 1987. 
Their study suggests uterine rupture was present in 4.8% of women who conceived within 12 
months of previous pregnancy but only.9% among women with an interpregnancy interval of 
more than 24 months(4). Compared with women who had an interpregnancy interval between 
18-23 months, women who conceived within 6 months of delivery had an increased risk of 
mortality (adjusted OR 2.5; 95% CI 1.2-5.4)(4).  Table 1.1 below shows the adjusted relative risk 
of women with adverse maternal outcomes by their interpregnancy spacing interval. Adjustments 
were made for maternal age, parity, demographics, and health characteristics. 
The most commonly cited poor health outcomes for children are low birthweight, preterm 
birth (18,20–27), small for gestational age (18,22,24,26,27), intrauterine growth restriction (28), 
stunting (29–33), underweight, low height for age, low weight for height (30,33–37), miscarriage 
(20,38), fetal death (21,38–40), and neonatal, infant and early childhood mortality (20,21,33,38–
40). Preterm birth, low birthweight and small-for-gestational age are all associated with both 
poor proximal and long-term birth outcomes for infants include physiological malformations, 
respiratory problems, sensory deficits, cognitive development delays and death(41,42). Table 1.2 
shows the adjusted odds of the most common adverse infant outcomes comparing those 
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conceived within six months of previous delivery and those with birth spacing between 18-23 
months. 
 In 2005, the World Health Organization (WHO) released a comprehensive technical 
report detailing the poor outcomes associated with short birth intervals. After reviewing the 
seminal literature and congregating thirty of the world’s leading experts on interpregnancy 
spacing, guidance was introduced recommending an interpregnancy period of no less than 24 
months(43). The American Congress of Obstetricians and Gynecologists recommends women in 
the United States have an interpregnancy period no less than 18 months citing increased risks of 
preterm birth, low birth weight and small-for-gestational age(44). Evidence suggests that there is 
a dose-response phenomenon to postpartum spacing and secondary conception. While 
conception is contraindicated for up to 24 months postpartum, conception within with the first 
six months postpartum has the highest risk for perinatal mortality, preterm birth, low birthweight, 
and fetal death is highest(43). The risk for these outcomes remains significantly elevated through 
months 7-18. According to ACOG, in month 18 postpartum, secondary conception is considered 
healthy. However, the World Health Organization maintains a more conservative estimate using 
24 months postpartum(43,45,46).  
 
Inadequate birth spacing is both common but easily preventable. In 2013, analysis of the 
National Survey of Family Growth determined that among the second or higher order births 
within the sample, 35% occurred within 18 months of a previous pregnancy. After controlling for 
demographic, social and parity characteristics, short birth intervals were significantly associated 
with adolescent age, being married and pregnancy being unintended. Additionally, researchers 
estimate that eliminating unintended pregnancies would reduce the proportion of pregnancies 
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within a short interval from 35% to 23%(47). Low educational attainment and use of less 
effective contraceptive during the postpartum period are associated with increased risk of 
unintended short interpregnancy interval(48). A study of women in California found that 47% of 
pregnancies in the postpartum period were unintended. There are significant variations in 
unintended pregnancy in the postpartum period across racial and ethnic groups. Unintended rapid 
repeat pregnancies were significantly associated with being African-American, US-born Latina, 
unmarried, adolescent, high parity (greater than five live births) and history of recent abuse. 
Women who were uninsured before pregnancy also had increased odds of having an unintended 
pregnancy(49).  
It is estimated that half of all women leave labor and delivery without any plan for 
postpartum contraception(46) and that early postpartum contraceptive initiation is key to long-
term use and prevention of unintended pregnancy(50). The Centers for Disease Control and 
Prevention has considered the risks of postpartum contraceptive initiation and established 
recommendations detailed below in Table 1.3. In this table, it is clear that intrauterine 
contraceptives, subdermal implants, progestin only pills, and injectable contraceptives are 
recommended in the postpartum period as the advantages and benefits of initiating the method 
outweigh the theoretical or proven risk for both breastfeeding and non-breastfeeding women 
(exceptions in the event of puerperal sepsis). It is not advised for women, both breastfeeding and 
not, to initiate estrogen-containing contraceptives such as the combined oral pill, the patch or the 
ring in the early postpartum period due to risks associated with the circulatory system(51). 
A 2005 study using New Mexico’s Pregnancy Risk Assessment Monitoring Survey 
(PRAMS) found that women who had a postpartum visit had three times the odds of initiating a 
contraceptive during the postpartum period(52). Another 2005 study found that among 712 
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women who expressed desire for immediate postpartum sterilization, 46% never received it. The 
most commonly cited factors associated with not receiving requested permanent contraception 
were young age, being African American or having a vaginal delivery(53). In light of this, the 
need for timely non-permanent contraceptive options is critical. The traditional timing of the first 
postpartum visit is considered six weeks however recent research has suggested it should be 
shortened to three weeks to allow for early initiation of postpartum contraception(54). Receipt of 
contraception at the first postpartum visit is significantly associated with increased birth interval 
spacing after controlling for demographic factors(3). As such the same researchers proposed a 
new paradigm they call the Rules of 3 that suggest i) If a woman is exclusively breastfeeding her 
infant, a contraceptive method should be used within 3 months postpartum ii) If a woman is 
partially or not breastfeed at all, a contraceptive method should be used within 3 weeks 
postpartum. The additional third suggestion is similar but addresses women who have elective or 
spontaneous abortions and are therefore beyond the scope of this proposal(54).  
 
Short-acting reversible contraceptives have high failure rates, poor adherence and low 
satisfaction rates.  Short-acting reversible contraceptives (SARCs) that require consistent user 
intervention such as the pill, patch or ring, all have failure rates of at least 9% in the first year of 
use. While effectiveness rates of 91% are high, these methods account for more than 30% of all 
contraceptive users in the United States. In any given month, 38% of women using oral 
contraceptive pills (OCP) miss at least one dose. Nearly 1 million pregnancies can be estimated 
to occur each year among American women relying exclusively upon oral contraceptive pills as 
their family planning method of choice; male condoms are only slightly higher at 1.15 million 
unintended pregnancy events per year(55). Nearly half of oral contraceptive pill users report not 
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being satisfied with their method; dissatisfaction is highly correlated with misuse and 
discontinuation with adequate replacement(55). Among women studied in 2011 for the North 
Carolina Pregnancy Risk Assessment Monitoring System, 29.3% of women in the postpartum 
period rely on pills to prevent pregnancy.  
 
Long acting reversible contraceptives are highly effective, cost effective and 
underutilized by women in the North Carolina. Long acting reversible contraceptives 
(LARCs) include intrauterine contraceptives and subdermal implants. LARCs are more than 
99.9% effective once placed by a medical provider and require no patient action until desired 
removal. Subdermal implants are effective for up to three years and intrauterine devices are 
effective between 5-15 years, depending on the method chosen. LARCs can be removed at any 
point by a provider with minimal effects on immediate fertility and no effect on long-term 
fertility(1). Once placed, a woman has protection from pregnancy that is more effective than 
nonreversible tubal ligation(56). Evidence shows that women who have a LARC placed and 
maintain it for six months have satisfaction rates of over 80%, compared to 54% of oral 
contraceptive pill users(57). In December 2009, the American Congress of Obstetricians and 
Gynecologists sent waves throughout family planning communities with their overwhelming 
endorsement of long-acting reversible contraceptives (LARCs). “According to the World Health 
Organization’s evidence-based Medical Eligibility Criteria for contraceptive use, LARC methods 
have few contraindications, and almost all women are eligible for implants and intrauterine 
devices. Because of these advantages and the potential to reduce unintended pregnancy rates, 
LARC methods should be offered as first-line contraceptive methods and encouraged as options 
for most women”(58). The Congress reaffirmed this document again in 2011 and supplemented 
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once again in October 2012 with additional explicit supports for adolescents and women in the 
postpartum and postabortion period(59). 
Possibly the most influential reason that LARCs are the most highly effective contraceptive 
methods is the lack of effort required by users to continue near perfect protection; a number of 
professionals call LARCs “Forgettable Contraceptives”. A recent study conducted at Washington 
University in St. Louis, The Contraceptive Choice Project, has shed great light on contraceptive 
satisfaction and continuation rates across both long and short-acting methods. Among 5,000 
sexually active women who were given adequate education of all available methods and for 
whom all expenses were covered, 69.9% of women chose to use a LARC. Women using the 
LARCs had the highest continuation rates among reversible methods at 87% and were more 
likely to report being satisfied with their method compared with OCP users(57). Long-acting 
reversible contraceptives have been specifically identified as the most promising intervention to 
prevent short interpregnancy interval(60). Figure 1.3 shows the failure rates for each method(61). 
In 2008, 30% of women in the postpartum period relied on a contraceptive method with a failure 
rate of greater than 20% within the first year of use(9). 
Long-acting methods have also been shown to be more cost-effective than short-acting 
methods. Trussell and colleagues used a comprehensive Markov model to simulate five year 
costs of contraceptive by incorporating not only the cost of the method but costs of providers, 
side effects and failure events into their analysis. They calculated total costs as well as the 
incremental cost effectiveness of methods over a five-year period. The intrauterine devices are 
the least costly reversible methods (Cu-IU $647, Lng-IUD $930) will oral contraceptive pills 
cost $3381 (62).  
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Most research has focused on maternal characteristics and insurance status as the 
primary factors associated with postpartum contraceptive initiation. Previous research has 
focused only on maternal characteristics such as age, race, education attainment, religious 
affiliation, previous pregnancy, previous abortion and insurance status(2,50,63–65). In a study 
using New Mexico’s PRAMS data, postpartum contraceptive initiation was significantly 
associated with being between the ages of 20-34, being married, having at least a high school 
education, being white, and having a postpartum visit(52). However, in a small telephone survey 
of postpartum women in the United States, being black, not having a college education and a 
household income of less that $40,000 was significantly associated with increased probability of 
receiving antepartum contraceptive counseling(50). These differences produced within the same 
year highlight the need for more rigorous, comprehensive analysis of postpartum contraceptive 
initiation behaviors as is possible through a large insurance claims dataset. This analysis will 
include many of the previously examined maternal covariates among a privately insured 
population while also introducing attributes of providers and health care settings to further 
explain the relationship between women and the postpartum contraceptive practices. 
 
This study expands upon the limited existing literature that demonstrates contraceptive 
utilization is associated with provider and perinatal care characteristics. While previous 
studies have examined the relationship between providers and their contraceptive counseling and 
prescribing patterns, study populations have been small and often convenience samples. The 
findings, however, have shared similar trends and have motivated the need for a larger, more 
comprehensive analysis. Thus far, evidence suggests younger providers, female providers and 
providers trained in obstetrics and gynecology are most likely to be knowledgeable about 
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updated contraceptive practice and more likely to provide long-acting methods (66–68). Small, 
qualitative studies have also found that many family medicine practitioners are not adequately 
trained in family planning; there are currently multiple national initiatives underway to improve 
family medicine practitioners’ knowledge and skills related to all contraceptives with an 
emphasis on long-acting methods(69,70). Patient-provider miscommunication about 
contraceptive effectiveness is believed to be strongly associated with misuse, discontinuation and 
subsequent unintended pregnancies(67). This research will be among the first large, quantitative 
projects to assess the role of provider characteristics with respect to postpartum contraceptive 
initiation and short interpregnancy interval among privately insured women throughout an entire 
state. 
Additionally, there is evidence that characteristics of the facility where women receive 
perinatal care are also associated with postpartum contraceptive initiation practices.  Women 
who receive perinatal care in rural areas of the United States lack comparable reproductive health 
services as compared to urban women; factors such as poverty, geographic isolation, insufficient 
numbers of appropriately trained providers, lack of transportation and lower rates of insurance 
are all thought to be contributors. Rural women are less likely to receive prenatal and postpartum 
care(71). Women in rural communities are also more likely to face the inability to acquire 
prescription contraceptives if local pharmacists refuse to dispense due to their own moral 
objections(72,73). Women in rural areas are less likely to rely upon reversible contraceptive 
methods yet more likely to rely on permanent sterilization as compared with women in 
metropolitan areas(74,75). This may be related to challenges women in rural areas face reliably 
accessing highly-effective reversible contraceptives. 
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 For these reasons, there is an established gap in the literature describing the relationship 
between perinatal care provider, care setting, timely association of postpartum contraceptive 
initiation and short interpregnancy interval. There is clear evidence that in North Carolina, 
postpartum contraceptive initiation and birth spacing are problematic and may be contributing to 
poor birth outcomes described in the literature.  
 
Innovation 
 The novelty of this study is that the key factors of interest are characteristics of the 
providers and settings in which women receive perinatal and delivery care. This research will 
look at women as active participants within health systems and examine the role between health 
care setting characteristics and postpartum contraceptive initiation while controlling for common 
demographic factors such as age, education, marital status and parity - all traits associated with 
contraceptive utilization. Much of the contemporary research regarding postpartum contraceptive 
initiation has exclusively studied maternal characteristics, insurance coverage and pregnancy 
intentions. The proposed study uses only insured women, controls for personal and social 
characteristic, and views short interpregnancy interval as a poor health outcome for both women 
and children, regardless of intention. This allows analyses to be tailored to the perinatal health 
care setting and provider characteristics that may be instrumental in a woman’s timely initiation 
of postpartum contraceptive. Furthermore, this analysis will provide a foundation upon which a 
major insurance network can explore the factors that may support or inhibit timely postpartum 
contraception and build evidence that may be used in future quality improvement efforts.  
 Additionally, the timeliness of this research is ideal. The Affordable Care Act recently 
enacted new laws affecting contraceptive coverage and out-of-
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August 1, 2012. Under the new legislation, insurance plans are required to cover all FDA 
approved contraceptive methods with no copayment (this includes pills, patches, rings, 
injectables, diaphragms, cervical caps and permanent sterilization)(76). This legislation has been 
contested across the country by employers and insurance plans citing religious and moral 
objection; the U.S. Supreme Court ruled that some religious employers and closely-held for-
profit companies can withhold contraceptive benefits from their employers(76). One caveat and 
often described as a “loophole” to this legislation that has been seen in practice from insurance 
plans across the country is a large out-of-pocket copayment for long-acting reversible 
contraceptive “insertion fees”.  Copayment information for various plans and methods are 
available within this dataset and can be examined for discontinuity trends that may be the result 
of changing legislation. In particular, there may be obvious shifts in contraceptive practices after 
the legislation on August 1, 2012 such as increased utilization of any method or methods that 
previously has higher out-of-pocket expenses. I will need to consider and adjust for this potential 
discontinuity pattern should the data show significant shifts via a fixed effect model. 
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Tables and Figures 
Table 1.1 Adjusted Relative Risk and 95% Confidence Intervals of Adverse Maternal 
Events by Interpartum Spacing Interval 
 Postpartum Interval, in months 
 0-5 6-11 12-17 18-23 24-59 ≥60 
Third trimester bleeding 
1.73*  
(1.42-2.24) 
1.03  
(0.91 - 1.16) 
1.01  
(0.88 - 1.14) 
1 1.04  
(0.96 - 1.14) 
1.12 
 (1.00 - 1.24) 
Premature rupture of 
membranes 
1.72*  
(1.53 - 1.93) 
1.04  
(0.96 - 1.12) 
1.02  
(0.93 - 1.12) 
1 1.08  
(0.98 - 1.19) 
1.03  
(0.93 - 1.14) 
Puerperal endometritis 
1.33*  
(1.22 - 1.45) 
1.04  
(0.94 - 1.14) 
1.08 
 (1.00 - 1.17) 
1 0.99  
(0.94 - 1.04) 
1.04  
(0.94 - 1.15) 
Anemia 
1.30*  
(1.18 - 1.43) 
1.03  
(0.95 - 1.12) 
1.02 
 (0.96 - 1.09) 
1 1.04  
(0.99 - 1.10) 
1.01  
(0.97 - 1.05) 
Maternal death 
2.54*  
(1.22 - 5.38) 
1.11  
(0.53 - 2.28) 
1.03  
(0.56 - 2.22) 
1 1.14  
(0.63 - 2.41) 
1.07 
 (0.71 - 2.71) 
       
Source: Conde et al. (21) 
 
Table 1.2 Adjusted Odds Ratio and 95% Confidence Intervals of Adverse Infant  
Events by Interpartum Spacing Interval 
Table 3. Adjusted Odds Ratio and 95% Confidence Intervals of Adverse 
Infant Events by Interpartum Spacing Interval 
 Postpartum Interval, in months 
 0-6 18-23 
Low birthweight (<2501 grams) 
1.4 
(1.24-1.58) 
1 
Preterm birth (<37 weeks gestation) 
1.61 
(1.39-1.86) 
1 
Small for gestational age 
1.26 
(1.18-1.33) 
1 
Source: Conde et al. (21) 
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Table 1.3 Summary of recommendations and risk classifications* for hormonal 
contraceptive methods and intrauterine devices during the postpartum period 
 COC/P/R POP DMPA Implant LNG-
IUD 
Cu-
IUD 
Postpartum (nonbreastfeeding women)       
a. <21 days 4 1 1 1   
b. 21 days to 42 days       
i. With other risk factors for VTE (such as age ≥35 years, previous 
VTE, thrombophilia, immobility, transfusion at delivery, BMI ≥30, 
postpartum hemorrhage, postcesarean delivery, preeclampsia or 
smoking) 
3† 1 1 1   
ii. Without other risk factors for VTE 2 1 1 1   
c. >42 days 1 1 1 1   
Postpartum (breastfeeding women§)       
a. <21 days 4 2 2 2   
b. 21 to <30 days       
i. With other risk factors for VTE (such as age ≥35 years, previous 
VTE, thrombophilia, immobility, transfusion at delivery, BMI ≥30 
kg/m2, postpartum hemorrhage, postcesarean delivery, preeclampsia 
or smoking) 
3† 2 2 2   
ii. Without other risk factors for VTE 3 2 2 2   
c. 30--42 days       
i. With other risk factors for VTE (such as age ≥35 years, previous 
VTE, thrombophilia, immobility, transfusion at delivery, BMI ≥30, 
postpartum hemorrhage, postcesarean delivery, preeclampsia or 
smoking) 
3† 1 1 1   
ii. Without other risk factors for VTE 2 1 1 1   
d. >42 days 2 1 1 1   
Postpartum (breastfeeding or nonbreastfeeding women, including 
postcesarean delivery) 
      
a. <10 min after delivery of the placenta     2 1 
b. 10 min after delivery of the placenta to <4 weeks     2 2 
c. ≥4 weeks     1 1 
d. Puerperal sepsis     4 4 
Abbreviations: COC = combined oral contraceptives; P = combined hormonal patch; R = combined vaginal ring; POP = 
progestin-only pill; DMPA = depot medroxyprogesterone acetate; IUD = intrauterine device; LNG-IUD = 
levonorgestrel-releasing IUD; Cu-IUD = copper-bearing IUD; VTE = venous thromboembolism; CHC = combined 
hormonal contraceptive; BMI = body mass index (weight [kg] / height [m2]). 
* Categories: 1 = a condition for which there is no restriction for the use of the contraceptive method, 2 = a condition for 
which the advantages of using the method generally outweigh the theoretical or proven risks, 3 = a condition for which 
the theoretical or proven risks usually outweigh the advantages of using the method, 4 = a condition that represents an 
unacceptable health risk if the contraceptive method is used. 
† Clarification: For women with other risk factors for VTE, these risk factors might increase the classification to a "4"; 
for example, smoking, deep venous thrombosis/pulmonary embolism, known thrombogenic mutations, and peripartum 
cardiomyopathy. 
§ The breastfeeding recommendations are divided by month in U.S. Medical Eligibility Criteria for Contraceptive Use, 
2010. They have been divided by days for purposes of integration with the postpartum recommendations. 
Source: CDC (51) 
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Figure 1.1 Perinatal Risk Factors and Outcomes in North Carolina and the  
United States, 2013 
 
Figure 1.2 Pregnancy Risk Factors and Outcomes in North Carolina  
by Urbanicity, 2013 
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Figure 1.3 Twelve Month Contraceptive Failure Rates, by Method 
 
 
Source:	  Contraceptive	  Technology	  (61)	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CHAPTER 2: PROPOSED APPROACH 
 
Overview and Rational  
 This research will address how key health system characteristics are associated with 
postpartum contraceptive initiation, initiation of highly effective contraceptive methods and the 
incidence of short interpregnancy interval among privately insured women in North Carolina. 
Prior literature has emphasized the role of individual characteristics as the key predictors of 
postpartum contraception initiation; this study will explore if health setting characteristics are 
strong predictors of postpartum contraceptive initiation and method of initiation after controlling 
for individual characteristics. 
 
Conceptual Model 
 This project will utilize an adaptation to the Anderson Health Services Research Model. 
The model, originally developed in the 1960’s, explores health care utilization by examining the 
interactive relationships between environmental, population, and behavioral factors and health 
outcomes(77). The author expanded upon this model again in 1995 describing how each of the 
predetermining factors were associated with potential, realized, equitable and inequitable access 
to health services(78). For this study, I will primarily examine how environment (urbanicity) and 
enabling resources (perinatal care facility and provider) affect health behaviors (initiating 
postpartum contraceptive) that lead to health outcomes (short interpregnancy interval).  I will 
control for as many predisposing characteristics as possible including maternal age, parity, 
	   21 
education, partnership status, and employment status; these individual level predisposing 
characteristics described in the model have already been thoroughly researched and shown 
associations with contraceptive initiation and birth outcomes as described above as described 
previously.  
 
Environment: Women live and receive healthcare within an environmental context. In 
accordance with the literature, women in rural communities are less likely to receive adequate 
reproductive health care(71,75). I will model how a woman’s geographic environment, though 
distal to her postpartum contraceptive practices, may play a significant role in her perinatal care. 
I predict women who enter thee conceptual pathway from a rural community will have poorer 
outcomes, even while holding all other factors constant.  
Predisposing Characteristics: Previous research has demonstrated strong relationships between 
maternal characteristics and contraceptive initiation and rapid repeat pregnancies. The most 
commonly cited predisposing characteristics in literature are maternal age, parity, education 
status, income and employment status.(2,50,63,64). Given the abundance of literature and the 
health services focus of this research, I propose to use women’s predisposing characteristics as 
control variables on the conceptual pathway. I accept their great importance in predicting a 
woman’s contraception practices but will use them   
Enabling Resources: The primary basis of this research project is to assess how variations in 
enabling recourses affect health behaviors and health outcomes. I will explore how when women 
of similarly predisposed characteristics interact with perinatal health care facilities and providers 
their health behaviors and outcomes vary.  The literature has substantiated that facility and 
provider characteristics are associated with contraceptive counseling and care practices; this 
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analysis will consider each component of the facility and provider individually and together to 
assess what types of perinatal care experiences best support timely initiation of postpartum 
contraceptives. 
Need: Postpartum contraceptive needs, both real and perceived, play a role in women’s decision 
to initiate a contraceptive method. Individual need is a factor determined by natural return to 
fertility, sexual activity, and breastfeeding practices. It has been estimated that among non-
breastfeeding women, fertility returns on average within six weeks, though some women may 
ovulate within 3 weeks(79). While breastfeeding may reduce fertility, there is not clear evidence 
as to the degree and length of natural protection against pregnancy due to highly variable 
breastfeeding practice(80). Periodic abstinence is also a means of contraception though the 
duration of use is highly variable and often unpredictable(81). Given such variation, I will view 
need to initiate postpartum contraception as determined by the current ACOG standards of  
Health Behaviors: This analysis will explore three health behaviors known to influence short 
interpregnancy interval. I will explore how perinatal care setting and providers are associated 
with return for postpartum care as well as any initiation of a contraceptive and its adherence. 
Usually, these three behaviors are considered to progress in a linear fashion; encountering a 
health provider, initiating a contraceptive method, and adhering or discontinuing that method. 
This model will explore how perinatal care characteristics are associated with these behaviors. 
Outcomes: The primary outcomes of interest in this study are the incidence of short 
interpregnancy interval, the interpregnancy pregnancy interval, birth outcomes of secondary 
pregnancy and related healthcare expenditures. I propose these outcomes are directly related to 
health behaviors but are also influenced indirectly by a woman’s predisposing characteristics and 
enabling resources.  
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Figure 2.1 shows the the proposed pathways using the Anderson model. 
 
Data Sources and Population 
 This study used professional, facility and pharmaceutical administrative claims from a 
large, private insurer in North Carolina. The professional and facility claims contained 
information on diagnoses and procedures as well as information on providers such as their name, 
specialty, place of business, and National Provider Identifier (NPI). Provider specialty was 
denoted as the primary specialty associated with a provider’s NPI. Table 2.1 defines the provider 
specialty groups used in analysis that primarily included Obstetricians/Gynecologists and Family 
Medicine providers. The pharmaceutical claims provided the name of the drug filled, dosage and 
refill status. In addition to claims, we also used a membership file that provided information on 
the insured person including date of birth, ZIP code of residence, employment status and 
insurance coverage information.  Due to the limited individual level characteristics included in 
the membership file, we also used ZIP code level demographics from the 2010-2014 5-Year 
Census’ American Community Survey such as race/ethnicity proportion, poverty indicators and 
educational information. Finally, we determined each ZIP code’s rurality status using the Rural 
Urban Commuting Area (RUCA) codes (82).The RUCA classifications include four groups: 
urban, large rural, small rural and isolated rural.  
 
Proposed Analyses 
Aim 1 Hypotheses 1.1: Women who receive perinatal care in an urban setting or at within a 
setting that has an OB/GYN residency program are more likely to initiate any modern 
contraception within 12 weeks of delivery.  
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This hypothesis will be tested using a 2SRI logistic regression model to predict the 
probability of timely initiation of any modern contraceptives given urban perinatal care site, 
presence of an OB/GYN residency program and the interaction of the two together. The first 
stage, described above when addressing selection bias, uses instrumental variables to address 
potential selection bias of perinatal care site and contraceptive method. The second stage uses a 
logit model with the endogenous variables and residuals from the first stage to estimate the 
probability of a woman initiating any contraceptive method within 12 weeks of delivery. 
Goodness of fit and specification tests will be included to ensure the model is appropriate 
constructed to the data; these include but are not limited to a Wald test to determine if 
coefficients are not equal to zero in the model (such as urban or OB/GYN practice), the 
LaGrange Multiplier tests to determine if adding variable jointly (such as urban and OB/GYN 
practice) significantly improves the model, and an AIC/BIC test to assess if higher ordered terms 
(such as quadratic age) or interaction terms (such as age*urban) would improve model fit.   
 
Equation 1.1  𝑃 𝐶𝑜𝑛𝑡𝑟𝑎𝑐𝑒𝑝𝑡𝑖𝑣𝑒	  𝐼𝑛𝑖𝑡𝑖𝑎𝑡𝑖𝑜𝑛 = 	   11 + 𝑒234 𝑤ℎ𝑒𝑟𝑒	  𝑥𝛽 = 𝛽9 +	  𝛽: 𝑈𝑟𝑏𝑎𝑛	  𝐹𝑎𝑐𝑖𝑙𝑖𝑡𝑦 + 𝛽@ 𝑂𝑏𝐺𝑦𝑛	  𝑅𝑒𝑠𝑖𝑑𝑒𝑛𝑐𝑦+ 𝛽F 𝑈𝑟𝑏𝑎𝑛 ∗ 𝑂𝑏𝐺𝑦𝑛	  𝑅𝑒𝑠𝑖𝑑𝑒𝑛𝑐𝑦 +	  	  	  	  	  	  𝛽H 𝑀𝑎𝑡𝑒𝑟𝑛𝑎𝑙	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠+ 𝛽J 𝑆𝑜𝑐𝑖𝑎𝑙	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠	  𝑜𝑓	  𝑍𝑖𝑝	  𝐶𝑜𝑑𝑒+ 𝛽N 𝐷𝑒𝑙𝑖𝑣𝑒𝑟𝑦	  𝐹𝑎𝑐𝑖𝑙𝑖𝑡𝑦	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠 + 𝛽P(𝑃𝑟𝑜𝑣𝑖𝑑𝑒𝑟	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠))+ 𝛽S 𝐶𝑜𝑛𝑡𝑟𝑎𝑐𝑒𝑝𝑡𝑖𝑣𝑒	  𝐶ℎ𝑜𝑖𝑐𝑒 + 𝛽T 𝑃𝑒𝑟𝑖𝑛𝑎𝑡𝑎𝑙	  𝐶𝑎𝑟𝑒	  𝑆𝑖𝑡𝑒	  𝐶ℎ𝑜𝑖𝑐𝑒  
 
Aim 1 Hypothesis 1.2: Among women who initiate any contraceptive, women receiving 
perinatal care in an urban setting or at within a setting that has an OB/GYN residency program 
are more likely to initiate a long-acting reversible contraceptive within 12 weeks postpartum. 
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 The test of this hypothesis will use a 2SRI nested multinomial logistic regression model, 
which accounts for choice in a sequential manner. The first stage, described above when 
addressing selection bias, uses instrumental variables to address potential selection bias of 
perinatal care site and contraceptive method. The second stage uses a nested multinomial model 
with the endogenous variables and residuals from the first stage to estimate the probability of a 
woman initiating a particular method of contraceptive within 12 weeks. The first nest of the 
model assesses whether a woman initiates a long-acting or short-acting reversible contraceptive. 
The second nest beneath this decision and determines which contraceptive method was initiated 
(pill, patch, ring, injectable, subdermal implant, intrauterine device). The nested multinomial 
model allows for multiple categorical outcomes while relaxing some of the parameters of the 
Independence of Irrelevant Alternatives (IIA), allowing nested outcomes to be correlated.  This 
model can be used to estimate the probability of a woman initiating any postpartum 
contraception as well the type. In the multinomial model, j indicates the category and I indicates 
the individuals.  Only characteristics of the individual, not the choices, are determinant in the 
model.  Figure 2.2 shows the proposed nested structure of the multinomial model. 
 
Equation 1.2 
𝑝UV = 𝑒3W4X1 + ΣZ[@\ 𝑒3W4X 𝑤ℎ𝑒𝑟𝑒	  𝑥𝛽 = 𝛽9 +	  𝛽: 𝑀𝑎𝑡𝑒𝑟𝑛𝑎𝑙	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠+ 𝛽@ 𝑆𝑜𝑐𝑖𝑎𝑙	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠	  𝑜𝑓	  𝑍𝑖𝑝	  𝐶𝑜𝑑𝑒+ 𝛽F 𝑃𝑟𝑒𝑛𝑎𝑡𝑎𝑙	  𝐶𝑎𝑟𝑒	  𝐹𝑎𝑐𝑖𝑙𝑖𝑡𝑦	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠+ 𝛽H(𝑃𝑟𝑜𝑣𝑖𝑑𝑒𝑟	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠)	  ) + 𝛽J 𝐶𝑜𝑛𝑡𝑟𝑎𝑐𝑒𝑝𝑡𝑖𝑣𝑒	  𝐶ℎ𝑜𝑖𝑐𝑒+ 𝛽N 𝑃𝑒𝑟𝑖𝑛𝑎𝑡𝑎𝑙	  𝐶𝑎𝑟𝑒	  𝑆𝑖𝑡𝑒	  𝐶ℎ𝑜𝑖𝑐𝑒  
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 In the first stage of the model, j represents the dichotomous variable of LARC or SARC 
(1=LARC, 0=SARC). In the second level, the nested level, the j categories represent the various 
modern methods available (Lng-IUD, Cu-IUD, Implant, COC/POP, patch, ring, DMPA). For this 
study, the methods of interest (k) include the LARCs, both intrauterine device options and 
subdermal implant and the SARCS, oral contraceptive pills (COC/POP), hormonal patch, 
hormonal ring, or injectable (DMPA). The referent category will be oral contraceptive pills as 
they are the most commonly used modern contraceptive. This nested multinomial method will be 
used to generate predicted probabilities and the most precise standard errors possible through 
1,000 bootstrapping repetitions. Bootstrapping is imperative in multinomial models to measure 
the precision of a differential effect as the model does not account for any coefficient variation.   
Various tests will be conducted to determine if this model appropriately fits the dataset. The first 
priority will be to test for Independence of Irrelevant Alternatives (IIA) which requires that the 
ratio of probabilities is constant even if a category is dropped; the standard Haussmann test is an 
appropriate test for IIA. If the IIA test fails, I will reconsider how variables are nested and 
explore alternatives that pass the IIA test and are able to answer the research question. In 
particular, if the nested model fails with the six contraceptive methods, I will regroup the 
methods dichotomously to SARC and LARC.  
 
Aim 2 Hypothesis 2.1: Among women who initiate any modern contraceptive within the first 12 
weeks postpartum, women who initiate a SARC within 12 weeks of delivery are more likely to 
have a short interpregnancy interval compared with women who initiate a LARC.  
A 2SRI logistic regression will be used to test this hypothesis similarly to Aim 1. The 
first stage, described above when addressing selection bias, uses instrumental variables to 
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address potential selection bias of perinatal care site and contraceptive method.  The second 
stage uses a logit model with the endogenous variables and residuals from the first stage and 
estimates the probability of short interpregnancy interval. Goodness of fit and specification tests 
will be included to ensure the model is appropriate constructed to the data; these include but are 
not limited to a Wald test to determine if coefficients are not equal to zero in the model, the 
LaGrange Multiplier tests to determine if adding variables jointly significantly improves the 
model, and an AIC/BIC test to assess if higher ordered terms or interaction terms would improve 
model fit.   
 
Equation 2.1 𝑃 𝑅𝑅𝑃 = 1 𝐶𝑜𝑛𝑟𝑎𝑐𝑒𝑝𝑡𝑖𝑣𝑒	  𝑀𝑒𝑡ℎ𝑜𝑑 = 	   11 + 𝑒234 𝑤ℎ𝑒𝑟𝑒	  𝑥𝛽 = 𝛽9 +	  𝛽: 𝑀𝑎𝑡𝑒𝑟𝑛𝑎𝑙	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠 +𝛽@ 𝑆𝑜𝑐𝑖𝑎𝑙	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠	  𝑜𝑓	  𝑍𝑖𝑝	  𝐶𝑜𝑑𝑒 + 𝛽F 𝑃𝑟𝑒𝑛𝑎𝑡𝑎𝑙	  𝐶𝑎𝑟𝑒	  𝐹𝑎𝑐𝑖𝑙𝑖𝑡𝑦	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠 +𝛽H(𝑃𝑟𝑜𝑣𝑖𝑑𝑒𝑟	  𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠) + 𝛽J 𝐶𝑜𝑛𝑡𝑟𝑎𝑐𝑒𝑝𝑡𝑖𝑣𝑒	  𝐶ℎ𝑜𝑖𝑐𝑒 +𝛽N 𝑃𝑒𝑟𝑖𝑛𝑎𝑡𝑎𝑙	  𝐶𝑎𝑟𝑒	  𝑆𝑖𝑡𝑒	  𝐶ℎ𝑜𝑖𝑐𝑒 +𝛽P 𝐿𝐴𝑅𝐶  
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Tables and Figures 
Table 2.1 Key Measures and Definitions 
Interpregnancy Intervals 
Interpregnancy 
interval The time (months) between two live births 
Short interpregnancy 
interval An interpregnancy interval of <27 months 
Contraceptive Use  
Contraceptive 
initiation 
The first postpartum medical or pharmaceutical claim associated 
with beginning contraceptives; e.g. CPT code 58300- Insertion of 
an intrauterine device or prescription filled for oral contraceptive 
method 
Contraceptive non-
use 
No recoded claim for any contraceptive method within 24 
months of delivery 
Short-acting 
reversible 
contraception 
Includes hormonal pills, patch, vaginal ring and injectable 
Long-acting 
reversible 
contraceptive  
Includes both the hormonal and copper intrauterine devices as 
well as the subdermal implant 
Permanent 
sterilization Includes both tubal ligation and occlusion 
Contraceptive type Mutually exclusive categories of non-use, SARC, LARC, permanent 
Provider 
Characteristics  
Provider Specialty 
Designation 
The specialty code of the provider who received the payment for 
the maternity care 
Provider Specialty 
For this study, we categorized providers into the five largest 
groups: Obstetricians and Gynecologists, Family Medicine, 
Certified Nurse Midwives (CNM), Pediatrics and Multispecialty 
Practice. During analysis, we did not interpret the findings 
associated with women seen by CNMs due to a very small 
sample. Additionally, Multispecialty Practice designation did not 
provide sufficient information for comparison with our referent 
group, OB/GYNs; it remained in the model as a covariate 
however could not be meaningfully interpreted given the lack of 
detailed information. 
Residency Affiliation 
Using the Accreditation Council for Graduate Medical Education 
directory, we identified those hospitals and practices associated 
with an OB/GYN residency training program. We allocated all 
providers at that site as "affiliated" to an OB/GYN residency 
program, regardless of specialty.  
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Distance to nearest 
OB/GYN residency 
program 
The distance (miles) from a woman's ZIP code centroid to the 
nearest accredited OB/GYN residency program; for multi-clinic 
practices, the central hospital was used as the end point 
Provider's LARC 
prescribing 
preference 
Among all non-permanent contraceptive prescriptions attributed 
to a provider, the proportion that are for a long-acting reversible 
contraceptive 
Demographic Characteristics 
Maternal age A woman's age on the day of delivery (years) 
Group health plan Binary indictor of whether a woman was enrolled in a group based insurance plan or individual plan 
Rural Residential zip code with RUCA classification of large rural, small rural or isolated rural 
Relative parity The number of live births a woman has within the data time frame 
White % The percent of a zip code identifying as White per Census estimates 
Black % The percent of a zip code identifying as Black per Census estimates 
Native 
American/American 
Indian % 
The percent of a zip code identifying as Native 
American/American Indian per Census estimates  
Asian % The percent of a zip code identifying as Asian per Census estimates 
Native 
Hawaiian/Pacific 
Islander % 
The percent of a zip code identifying as Native Hawaiian/Pacific 
Islander per Census estimates 
Hispanic % The percent of a zip code identifying as Hispanic per Census estimates; includes ALL races 
Females over 25 
without high school 
degree/GED % 
The percent of women in a zip code over age 25 without a high 
school diploma or GED equivalency per Census estimates 
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Figure 2.1 Anderson Model of Postpartum Contraceptive Initiation and Short 
Interpregnancy Intervals 
 
 
 
 
 
Figure 2.2 Nested multinomial model structure 
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CHAPTER 3: THE EFFECT OF MATERNITY CARE PROVIDER SPECIALTY, 
RESIDENCY AFFILIATION AND PATIENT RURALITY ON POSTPARTUM 
CONTRACEPTIVE INITIATION PATTERNS 
 
Overview 
Objective: To determine if provider and healthcare setting characteristics effect the timing and 
type of postpartum contraception initiation.    
Methods: Using administrative claims from a large, private insurance company, we assessed how 
provider specialty, provider association with an obstetrics and gynecology residency program 
and living in a rural area affected the time to and method of postpartum contraceptive initiation. 
The sample included 14,426 women with a live birth who were continuously insured for 60 
months after their first delivery claim. We used both a two-stage residual inclusion model and 
inverse probability of treatment weighted logistic regression to determine the probability a 
woman would begin a contraceptive over time and whether she would use long-acting versus 
short-acting reversible contraceptives. 
Results: Approximately 65% of women in this sample initiated a contraceptive within 12 months 
postpartum and 29% initiating a long-acting reversible method. Among women in the sample, 
receiving care from a residency affiliated provider did not increase the probability of initiating 
contraceptives or a long-acting reversible method within 12 months postpartum (p>05). 
Additionally, we found no significant association between provider type at delivery and 
contraceptive timing. Living in a rural area also had no significant effect on postpartum 
contraceptive practices. However, receiving maternity care from a Family Medicine provider 
	   32 
increased utilization of long-acting reversible contraceptives within 12 months postpartum by 
13.6% and 25.3% in the 2SRI and IPTW models, respectively (p<.05), as compared with 
receiving care from an obstetrician/gynecologist. 
Conclusions: Provider specialty or affiliation with an OB/GYN residency program did not effect 
a woman’s time to contraceptive initiation; however, Family Medicine providers were linked to 
higher rates of LARC initiation as compared with OB/GYN specialists. These findings suggest 
that while OB/GYN providers may have the most formal training in contraception, the continuity 
of care a woman receives from a primary care provider before, during and after her pregnancy 
may play an important role in selecting a highly-effective contraceptive.  
 
Key words: contraception, postpartum care, postpartum contraception, birth spacing, long-acting 
reversible contraceptive 
 
Introduction/Background 
Modern contraceptives have led to a dramatic reduction in unintended pregnancies, teen birth 
rates, and poor infant outcomes since their introduction (1). Despite highly effective 
contraceptive interventions, half of all births in the United States are unintended and almost half 
of these are unwanted (2). Postpartum contraceptive initiation is a critical component of family 
planning and promoting healthy birth spacing. However, in a recent study in California among 
women with contraceptive coverage, only 41% of women had a contraceptive claim within 90 
days postpartum (3). Short birth intervals are associated with numerous poor outcomes for both 
women and infants (4) including eclampsia (10,11), anemia (12–14), uterine rupture (15–17), 
third trimester bleeding (12), premature membrane rupture (10,18), puerperal endometriosis 
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(12,18),  placental previa (19), maternal death (12,20,21), low birthweight, preterm birth (18,20–
27), small for gestational age (18,22,24,26,27), intrauterine growth restriction (28), stunting (29–
33), underweight, low height for age, low weight for height (30,33–37), miscarriage (20,38), 
fetal death (21,38–40), and neonatal, infant and early childhood mortality (20,21,33,38–40). 
Given these findings, the American Congress of Obstetricians and Gynecologists recommends 
women in the United States have an interpregnancy period of no less than 18 months citing 
increased risks of preterm birth, low birth weight and small-for-gestational age (44). 
However, it is estimated that half of all women leave labor and delivery without any plan for 
postpartum contraception (46). Early postpartum contraceptive initiation is key to long-term 
contraceptive use and prevention of unintended pregnancy  (38). The Centers for Disease Control 
and Prevention have established recommendations indicating that intrauterine contraceptives, 
subdermal implants, progestin only pills, and injectable contraceptives are recommended in the 
postpartum period as the advantages and benefits of initiating the method outweigh the risk for 
both breastfeeding and non-breastfeeding women (exceptions in the event of puerperal sepsis). 
Use of less effective contraceptives during the postpartum period are associated with 
increased risk of unintended short interpregnancy interval (48).  Short-acting reversible methods 
include all types of oral pills, hormonal patch, hormonal vaginal ring and injectable 
contraceptives and are considered among the lesser effective hormonal methods; the typical use 
failure rate for the injectable is 6% and 9% for the pill, patch, and vaginal ring.(61) Long-acting 
reversible methods include both the hormonal and copper intrauterine devices (IUDs) as well as 
the subdermal implant and have efficacy rates of greater than 99%.(61)  Existing literature and 
current medical recommendations  support women using the more effect LARCs in the early 
postpartum period (1,64,83). 
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Women who receive perinatal care in rural areas of the United States lack comparable 
reproductive health services as compared to urban women; factors such as poverty, geographic 
isolation, insufficient numbers of appropriately trained providers, lack of transportation and 
lower rates of insurance are all thought to be contributors. Rural women are less likely to receive 
prenatal and postpartum care (71). Women in rural communities are also more likely to face the 
inability to acquire prescription contraceptives if local pharmacists refuse to dispense due to their 
own moral objections (72,73). Women in rural areas are less likely to rely upon any reversible 
contraceptive methods yet more likely to rely on permanent sterilization as compared with 
women in metropolitan areas (74,75). This may be related to challenges women in rural areas 
face in reliably accessing highly-effective reversible contraceptives. 
Much of the existing research on postpartum contraceptive initiation has focused only on 
maternal characteristics such as age, race, education attainment, religious affiliation, previous 
pregnancy, previous abortion and insurance status (2,50,63–65) . Thus far, evidence suggests 
younger providers, female providers and providers with training in obstetrics and gynecology are 
most likely to be knowledgeable about updated contraceptive practice and more likely to provide 
long-acting methods (66–68). Small, qualitative studies have also found that many family 
medicine practitioners are not adequately trained in family planning; there are currently multiple 
national initiatives underway to improve family medicine practitioners’ knowledge and skills 
related to all contraceptives with an emphasis on long-acting methods (69,70). Patient-provider 
miscommunication about contraceptive effectiveness is believed to be strongly associated with 
misuse, discontinuation and subsequent unintended pregnancies (67).  
This study aims to estimate the potential effects of provider specialty, provider affiliation 
with an OB/GYN residency site and living in a rural community on both the timing to and 
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method of postpartum contraception. Given the existing literature, we hypothesized that women 
who received maternity care from an OB/GYN provider or a provider affiliated with an 
OB/GYN residency program would be more likely to initiate postpartum contraceptives within 3 
and 6 months as compared with women receiving care from other provider types. We 
hypothesized women who lived in rural areas would be less likely to use any contraceptive 
within 12 months postpartum. Finally, we hypothesized women who received maternity care 
from an OB/GYN provider or a provider affiliated with an OB/GYN residency program would 
be more likely to initiate a long-acting reversible contraceptive as compared with with women 
who received care from other provider types. We hypothesized women who lived in rural areas 
would be less likely to initiate a long-acting reversible contraceptive.  
 
Methods  
Data 
 This study used administrative claims data (professional, facility, and pharmaceutical) 
from a large, private insurance company in North Carolina. The professional and facility claims 
data included information on diagnoses, procedures completed, provider and facility 
characteristics. Provider information included name, specialty, National Provider Identifier 
(NPI), organization/practice name, and address of practice location. We recorded provider 
specialty based upon the specialty classification associated with the NPI. The pharmaceutical 
claims file included information on the name and type of drug, dosage, refill status, pharmacy 
identifier, and Drug Enforcement Agency (DEA) provider number. In addition, a membership 
file included a unique member identification number, date of birth, ZIP code of residence, and 
insurance coverage information. Additional data were included to offer a more complete profile 
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of women, their communities and their service providers. Due to the limited demographic 
indicators available within the membership data, zip code level characteristics such as 
race/ethnicity proportions, median income, and educational attainment were added from the 
2010-2014 American Community Survey. Additionally, urbanicity was determined by Rural 
Urban Commuting Area codes for a subscriber’s residential zip code (82). RUCA codes are often 
divided into four groups: urban, large rural, small rural, and isolated rural. For analytic purposes, 
we collapsed these categories into binary urban and rural designations.  
 This study used the Multi-Level Clinical Classification Software (CCS) for ICD-9-CM to 
standardize classification of both diagnoses and procedures (84). The CCS aggregates codes into 
useful groups for analysis such as combining all variations of a caesarian delivery (caesarian-
twins, caesarian without complications, caesarian with hemorrhage, etc.) into a single category 
labeled “Caesarian delivery”.  
 
Key Measures and Definitions 
The key measures for this study included time to contraceptive, type of contraceptive, 
provider specialty and OB/GYN residency site affiliation. Time to contraceptive was measured 
as the number of days after a live birth until the first indication of a contraceptive in claims. 
Contraceptive type is defined as non-use, short-acting reversible contraceptive (pills, patch, ring, 
injectable), long-acting reversible contraceptive (intrauterine device or subdermal implant), or 
permanent (tubal ligation or occlusion). In this study, we classified specialty into the five most 
common groups: OB/GYN, family medicine, certified nurse midwife, pediatrics and 
other/multispecialty practice. The insurance provider uses a global billing code for maternity 
services; the global billing code is used to reimburse a provider for most maternity related 
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services rendered. Global billing allows us to observe in claims which provider or practice 
provider prenatal, labor and delivery, and postpartum care to women. For our analysis, we used 
the provider associated with prenatal care maternity services as the designated provider for that 
pregnancy event.  A woman’s provider type was recorded based upon the provider who received 
payment for maternity care services (prenatal and postpartum care always, sometimes delivery 
care). We also denoted physicians as affiliated with an OB/GYN residency site if they practiced 
at a facility associated with one of Graduate Medical Education accredited residency programs in 
Obstetrics and Gynecology. Finally, we used ZIP code demographic indicators as controls in our 
model including the percent of a ZIP code population identifying with the major racial groups, 
Hispanic ethnicity, and women over 25 years of age without a high school diploma or equivalent 
degree. Table 3.1 below provides additional definitions and explanations for how we developed 
our key measures. 
 
Sample 
Our sample included female insurance members between the ages of 10-60 during the 
study period of January 2008-September 2014 with at least one live birth during the study period. 
We required women to have at least 60 months of continuous insurance coverage with a gap no 
greater than 3 months after their first live birth in the study period. Finally, we included only 
those women with complete zip code information to merge the necessary social and demographic 
characteristics of her residential zip code. The final analytic file represented 14,226 unique 
women and 19,848 live births. Figure 3.1 shows the sample design.  
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Analysis 
 
Time to Contraceptive 
Two-stage residual inclusion (2SRI) model 
For our analysis, we used live births as the unit of analysis. After each live birth, we 
calculate the amount of time until a woman initiates contraception. Within our dataset, there 
were 5,587 repeat births indicating multiple observations for some women. As described further 
below, we adjusted the standard errors of our models to account for repeated measures. We 
constructed an instrumental variable (IV) to address the selection bias inherent in women’s 
choice of clinical practices and provider. Numerous factors influence a woman’s decision to 
receive care in a particular facility including proximity, relationship to practice, type of provider, 
degree of pregnancy risk, and other unobserved factors (85).  As this study hypothesized that 
clinical providers and the practices in which they work are causally linked to postpartum 
contraceptive initiation, we address the unobserved factors related to selecting a provider 
associated with an OB/GYN residency program. We used the distance from the centroid of the 
residence zip code to the nearest OB/GYN residency site as an instrument for the selection of a 
healthcare provider at residency center in accordance with previous literature (86–88).  Figure 
3.2 shows the proposed instrumental pathway. We tested this instrument’s strength using a Wald 
test and found it to be strong with an F-stat of 29.56 at p<.00001. 
Using this instrument, we used a two stage residual inclusion (2SRI) model to determine 
first if a woman initiated any contraceptive method within 3,6, and 12 months postpartum.  The 
first stage addresses selection bias of clinic choice in a linear probability model using distance as 
an instrument and controlling for all other exogenous covariates.  The second stage uses a logit 
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model, the exogenous covariates, the endogenous variable (receiving care from a provider 
associated with an OB/GYN residency program) and the residuals from the first stage to estimate 
probability of contraceptive initiation at 3, 6 and 12 months postpartum. We then repeated the 
same first stage model among women who initiated a non-permanent method and predicted the 
probability of selecting a long-acting method within 12 months in the second stage. We then 
tested the instrument via the exclusion test. In doing so, we run the second stage of the model 
again with the instrument included (distance to nearest residency program); the instrument 
should not be significantly associated with the dependent variable. The model passed the 
exclusion test indicating the distance to a residency program only effected the dependent variable 
through the defined pathway we hypothesized. We then proceeded with confidence that our 
model met the proper criteria for an effective 2SRI model.  
For each outcome model, we bootstrapped the clustered standard errors by unique women 
500 times over both stages. This and other 2SRI models yield estimates that should be 
interpreted within a Local Average Treatment Effect (LATE) context. 
 
Inverse probability of treatment weights (IPTW) model 
In a secondary analysis, we used inverse probability of treatment weights (IPTWs) to 
estimate causal effects under the assumption of no unmeasured confounding. IPTWs are used to 
create similar distributions of measured covariates between treatment and control groups (89,90); 
for our study controls are those women who did not receive care from an OB/GYN residency 
affiliated provider and the intervention group are those who did.  For the IPTW model, we 
regressed treatment (receipt of care by OB/GYN residency provider) on the observed covariates 
believed to be associated with postpartum contraceptive initiation. From this model, we then 
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generated propensity scores and inverse weighted them based upon treatment assignment. We 
applied the weights and measured the balance of baseline risk factors; the weights achieve 
balance when the observed baseline risk factors have a standardized difference of less than 10% 
between the treatment and control group.  Table 3.4 shows the variables included as well as the 
weighted and unweighted covariate means and standardized differences. We then applied these 
weights to logistic regression models measuring contraceptive initiation at 3, 6 and 12 months 
postpartum and predicted the average marginal effects using clustered standard errors to account 
for repeated measures on women over time. This and other IPTW models yield estimates that 
should be interpreted within an Average Treatment Effect (ATE) context. 
 
Method of contraceptive 
Two-stage residual inclusion multinomial model 
 After establishing causal models associated with timing to postpartum contraception, we 
developed models to test how our key independent variables (provider specialty, provider 
affiliation with an OB/GYN residency program, and rural residence) effected the method of 
contraception a woman began in the postpartum period. We hypothesized based upon the 
existing literature that women receiving care from OB/GYN providers and those providers 
affiliated with OB/GYN residency programs would have higher uptake of LARCs.  We 
constructed a 2SRI multinomial model predicting the probability of initiation within 12 months 
by method types short-acting reversible method, long-acting reversible method, and permanent; 
the referent category was non-use of a contraceptive within 12 months postpartum. The model 
failed the Independence of Irrelevant Alternatives test under all method type exclusions and 
therefore was not considered appropriate for interpretation.  
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Inverse probability of treatment weights (IPTW) model 
To answer our question of the effect on the type of method initiated given the 
multinomial model failure, we then constructed a binary model predicted SARC or LARC 
among women who initiated a non-permanent contraceptive within 12 months and predicted the 
average marginal effects using clustered standard errors by unique woman. 
 
Results 
 The age at time of first delivery ranged from 14 to 53 with a mean of 31.8 years old. The 
sample was predominantly concentrated in urban areas (88%). Of those in the sample, nearly 
60% were the insurance subscriber while 39% were spouses and 1.8% were children of the 
subscriber. Approximately 89% of people in the sample were enrolled in a group health plan 
(Table 3.2). 
 Of the live births in the sample, 66% were delivered vaginally and 34% were delivered 
via a caesarian section (Table 3.3). The total number of live births per woman ranged from one 
to five during the study period with the mean relative parity of 1.3 births per woman. Ten percent 
of women received care from a provider affiliated with an OB/GYN residency program. 
Approximately 83% of births were attended to by an OB/GYN, 1.5% by a Family Medicine 
Provider, 1.0% by a Pediatrician, and .14% by a Certified Nurse Midwife (CNM). Additionally, 
14.7% of deliveries were attended to by a provider associated with a “Multispecialty Practice”; 
from these births we could not assess provider specialty (see Table 3.1 for further details).  
 Following a live birth, 33.9% of the time a woman did not initiate any form of observable 
contraceptive observable within 24 months of delivery (n=7,447); this is referred to as “non-use” 
in the tables and figures. Among women who initiated a contraceptive method, 61% used a 
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SARC, 28.7% used a LARC and 10.3% received permanent sterilization (Table 3.5). The most 
common methods initiated were oral contraceptive pills (57.3%), hormonal IUD (24.5%) and 
permanent sterilization (10.3%). The average time to contraceptive initiation following a vaginal, 
forceps or vacuum delivery was 170 days versus 275 days for women with a caesarian delivery. 
Time to initiation varied by method type with intrauterine devices, both copper and hormonal, 
being initiated at 150 and 162 days, respectively. In comparison, initiation of oral contraceptive 
pills occurred at an average of 180 days postpartum and subdermal implant at 185 days. The ring 
was the latest non-permanent method initiated at 312 days postpartum (Table 3.6). 
 
Contraceptive Initiation Timing Models 
2SRI Logistic Regression Model (Table 3.7) 
  The two-stage residual inclusion model presents result through a local average treatment 
effect (LATE) interpretation. This interpretation emphasizes that the measured effects is only 
among those observations for whom the instrument altered the outcome. As such, all results for 
the 2SRI models must be considered with the caveat that the effect reported is among women for 
whom distance affected contraceptive initiation.  In the two-stage residual inclusion models 
estimating the probability of contraceptive initiation at 3, 6 and 12 months postpartum, among 
women for whom distance affected their utilization of receiving care from a residency affiliated 
provider, receiving care from a residency affiliated provider was associated with a 7.1 and 6.0 
percentage point decrease in contraceptive initiation at 3 and 6 months postpartum (p<.05); there 
was no significant difference in contraceptive initiation within 12 months based upon the 
provider type. Women who had a caesarian delivery were significantly less likely to initiate a 
contraceptive at all time points, decreasing the predicted probability by 4.8, 4.6 and 4.0 
	   43 
percentage points at 3, 6 and 12 months postpartum, respectively (p<.001). There was a small 
positive association between increasing maternal age and increased probability of contraceptive 
initiation at all time points (p<.05). There was no significant effect of living in a rural area on 
timing of contraceptive initiation.  
  
IPTW Logistic Regression Model (Table 3.7) 
  In the model estimating initiation patterns weighted by inverse probability of treatment 
weights, receiving maternity care from a provider associated with an OB/GYN residency 
program had no significant effect on contraceptive initiation within 3, 6 or 12 months 
postpartum. There was no significant effect on initiation patterns among women whose 
provider’s specialty was Family Medicine or Pediatrics as compared with women who were 
attended to by an OB/GYN. Women who had a caesarian delivery were significantly less likely 
to initiate any contraceptive at 6 and 12 months, reducing the predicted probability by 3.6 and 
2.3 percentage points, respectively (p<.05). Women who lived in a rural area were significantly 
more likely to initiate a contraceptive method within 6 and 12 months by 6.9 and 3.5 percentage 
points, respectively (p<.05).  
 
Contraceptive Method Models 
2SRI Multinomial Logistic Regression Model (Table 3.8) 
The results of the two-stage multinomial logistic regression estimating the effect the key 
independent variables on initiating a certain type of contraceptive are displayed in Table 3.8 for 
illustrative purposes only; the model did not pass any variation of the test of Independence of 
Irrelevant Alternatives and should not be considered reliable (test results not shown).  
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2SRI Logistic Regression Model (Table 3.9) 
 Our final model tested how our key independent variables affected a woman’s choice to 
use a LARC within 12 months given that she began any non-permanent method. There was no 
significant association between receiving care from a provider associated with an OB/GYN 
residency site and the probability of initiating a long-acting reversible contraceptive versus a 
short-acting reversible contraceptive within 12 months postpartum. However, when compared 
with women who received care from an OB/GYN, those who received care from a Family 
Medicine provider were 13.6 percentage points more likely to initiate a long-acting contraceptive 
within 12 months postpartum (p<.05). There was no significant association between receiving 
care from a Pediatrician and LARC initiation at 12 months postpartum. As compared to women 
who had a vaginal delivery, women who had a caesarian delivery were 2.8 percentage points less 
likely to begin using a LARC by 12 months postpartum (p<.01). There was a positive association 
between maternal age and LARC initiation (p<.001) as well as an inverse relationship between a 
woman’s relative parity and LARC initiation (p<.001). There was no significant effect associated 
with living in a rural area.  
  
IPTW Logistic Regression Model (Table 3.9) 
 In the IPTW model predicting a woman’s likelihood of initiating a long-acting method 
given she began a non-permanent method within 12 months postpartum, there was no association 
between receiving care from a provider associated with an OB/GYN residency program. There 
was a large, significant effect on LARC initiation among women and girls who received care 
from a Family Medicine provider; women and girls who received delivery care from a Family 
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Medicine provider were 25.3 percentage points more likely to use a LARC within 12 months 
postpartum as compared to women who received care from and OB/GYN (p<.05). There was no 
significant difference between Pediatrician providers and OB/GYN providers. There was no 
significant difference in LARC initiation based upon having a caesarian delivery, maternal age or 
living in a rural area. 
   
Discussion 
 This study found through two different estimation methods that receiving care from a 
residency affiliated provider did not increase a woman’s probability of initiating contraceptives 
nor increase her probability of initiating a long-acting reversible method within 12 months 
postpartum (p<.05). In the 2SRI models, we actually found that for women for whom distance to 
residency affected their use of residency affiliated providers, residency affiliation actually 
decreased the probability of initiating any contraceptive within 3 or 6 months. There are several 
considerations to take into account when interpreting this finding. First, women who receive care 
from a teaching practice (residency affiliated) may have different maternal risk factors that are 
not observed within the data. For example, women at highest risk for complications may 
anticipate problems and chose to receive care from a provider associated with a more 
comprehensive neonatal intensive care unit (NICU); in the state studied, all level 4 NICUs (the 
most comprehensive/highest care level) were affiliated with a residency program. 
 Additionally, residency programs have providers with the most advanced training in 
terms of those teaching the skills of the field as well as the most novice of providers. From our 
data, we could not observe which residency affiliated providers were in training and those that 
were teaching. This may account for some of the negative effect as some providers may have 
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been at the very beginning of their careers and still learning how to most effectively meet the 
needs of women in the postpartum period.  
However, we did find that women who received care from a Family Medicine provider 
had increased LARC utilization in the postpartum period. These findings suggest that while 
OB/GYN providers typically have the most formal contraceptive training, there may be an added 
benefit to postpartum contraceptive initiation of receiving maternity care from a primary care 
provider. This could be indicative of the effects of an established relationship between primary 
care providers and women before, during, and after pregnancy. Additionally, while our study did 
not assess this, there may be additional points of contact between women and family medicine 
maternity care providers should their infants receive care from them as well; this would 
potentially increase opportunities to discuss postpartum contraceptive initiation at infant wellness 
visits such as when obtaining vaccinations or doing well-baby visits. In fact, according to Bright 
Futures, the American Academy of Pediatrics Guidelines for Health Supervision of Infants, 
Children and Adolescents, providers are recommended to discuss postpartum care and birth 
control with women at the one-month well-baby visit (91).  
 We also find higher contraceptive initiation patterns among women in rural areas  as 
compared with women in urban areas. This finding was also unexpected given the body of 
literature suggesting women in rural areas have less access to contraceptives(71,72,75). This may 
suggest that the unmet need for contraceptives in rural areas is diminishing or indicative of 
women in rural areas exerting more effort to prevent additional pregnancies. This may be 
associated with the significant strain of poverty, underemployment, and lower educational 
attainment opportunities in rural areas as described above; preventing additional pregnancies 
may be related to efforts to conserve limited resources within families.  
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Limitations 
This research has several limitations to consider. In the absence of a randomized control 
trial assigning women to residency affiliated providers, we implemented two methodologies used 
to address potentially endogenous variables: an instrumental variable and inverse probability of 
treatment weights. Though they vary in their results, both adjust for unobserved differences in 
participants at baseline. We accept that these models are useful in determining causation, 
however, there may be unobserved factors influencing outcomes that our models could not 
address. Additionally, inverse-probability of treatment weights have an additional limitation in 
that they can only weigh based upon observable characteristics in the data which may lead to 
greater unobserved variable bias. 
 Unobserved variables believed to affect provider selection include preexisting 
relationship with a provider, provider availability, proximity to services and risk level of a 
pregnancy. These factors are not included within the data and may lead to unobservable 
differences in the sample across provider types. Additionally, provider specialty type was 
denoted by the NPI used to bill for services rendered; this number could represent a single 
provider or a clinical practice. Some of the potential effect of provider specialty may be altered 
by how a practice bills for services (per individual provider or per the entire practice). For 
example, a Family Practice group consisting of five physicians may all bill the insurer under a 
practice level NPI restricting our ability to identify the specific provider seen by a woman during 
her pregnancy and postpartum period. While the practice is detonated as Family Medicine, they 
may have a Pediatrician on staff whose specialty will be recorded as Family Medicine. This may 
alter the specialty specific effects.  
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 There are also limitations to how we were able to measure contraceptive utilization. Our 
data only included information on contraceptives that were billed to the insurance company; 
contraceptives paid for out-of-pocket are not included in analysis. Condoms, natural family and 
partner vasectomy are also not available within the dataset. For this study we did not focus on the 
duration of contraceptive use or method switching but rather the timing and type of the first 
method used in the postpartum period. 
 Finally, our sample of women was narrow to women with at least 60 months of stable 
insurance coverage following a live birth. While this helps ensure that insurance coverage was 
not a factor in method initiation and selection, this limits generalizability of our study to other 
populations with potentially shorter insured periods such as those with Medicaid or new 
participants in the Affordable Care Act insurance exchanges.  
 
Conclusion 
 While we hypothesized OB/GYN providers and providers associated with an OB/GYN 
residency program would increase the probability of a woman initiating contraceptives within 12 
months and use LARC more often than other providers, our findings did not support this. While 
no provider type showed statistically different time to initiation patterns from OB/GYN 
providers, women who received care from Family Medicine providers were significantly more 
likely to initiate a LARC within 12 months postpartum. This finding may suggest that women 
who receive their maternity care from a primary care provider have greater access and support 
for contraceptive services in the postpartum period.  
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Tables and Figures 
Table 3.1 Key Measures and Definitions 
Contraceptive Use  
Contraceptive initiation 
The first postpartum medical or pharmaceutical claim associated with 
beginning contraceptives; e.g. CPT code 58300- Insertion of an 
intrauterine device or prescription filled for oral contraceptive method 
Time to contraceptive 
initiation The number of day from live birth to contraceptive initiation claim 
Contraceptive non-use No recoded claim for any contraceptive method within 24 months of delivery 
Short-acting reversible 
contraception Includes hormonal pills, patch, vaginal ring and injectable 
Long-acting reversible 
contraceptive  
Includes both the hormonal and copper intrauterine devices as well as 
the subdermal implant 
Permanent sterilization Includes both tubal ligation and exclusion 
Contraceptive type Mutually exclusive categories of non-use, SARC, LARC, permanent 
Provider Characteristics  
Provider Specialty 
Designation 
The specialty code of the provider who received the payment for the 
maternity care; this always included prenatal and postpartum services 
and may have included delivery 
Provider Specialty 
For this study, we categorized providers into the five largest groups: 
Obstetricians and Gynecologists, Family Medicine, Certified Nurse 
Midwives (CNM), Pediatrics and Multispecialty Practice. During 
analysis, we did not interpret the findings associated with women seen 
by CNMs due to a very small sample. Additionally, Multispecialty 
Practice designation did not provide sufficient information for 
comparison with our referent group, OB/GYNs; it remained in the 
model as a covariate however could not be meaningfully interpreted 
given the lack of detailed information. 
Residency Affiliation 
Using the Accreditation Council for Graduate Medical Education 
directory, we identified those hospitals and practices associated with an 
OB/GYN residency training program. We allocated all providers at that 
site as "affiliated" to an OB/GYN residency program, regardless of 
specialty.  
Distance to nearest 
OB/GYN residency 
program 
The distance (miles) from a woman's ZIP code centroid to the nearest 
accredited OB/GYN residency program; for multi-clinic practices, the 
central hospital was used as the end point 
Demographic Characteristics 
Maternal age A woman's age on the day of delivery (years) 
Rural Residential zip code with RUCA classification of large rural, small rural or isolated rural 
Relative parity The number of live births a woman has within the data time frame 
White % The percent of a zip code identifying as White per Census estimates 
Black % The percent of a zip code identifying as Black per Census estimates 
Native 
American/American 
Indian % 
The percent of a zip code identifying as Native American/American 
Indian per Census estimates 
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Asian % The percent of a zip code identifying as Asian per Census estimates 
Native Hawaiian/Pacific 
Islander % 
The percent of a zip code identifying as Native Hawaiian/Pacific 
Islander per Census estimates 
Hispanic % The percent of a zip code identifying as Hispanic per Census estimates; includes ALL races 
Females over 25 without 
high school degree/GED 
% 
The percent of women in a zip code over age 25 without a high school 
diploma or GED equivalency per Census estimates 
 
 
Table 3.2 Attributes of women in sample  
 n % 
Unique women in sample 14,226 - 
Number of discrete live births 19,848 - 
Age at time of event (mean) 31.81 - 
Insurance Membership Classification  
Insured Member    
Child 362 1.82 
Spouse 7,780 39.2 
Subscriber 11,704 58.97 
Other 2 0.01 
Geographic Attributes of ZIP Code  
Urban 18,010 87.98 
Large rural 1,503 7.34 
Small rural 519 2.54 
Isolated rural 438 2.14 
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Table 3.3 Attributes of live births in sample  
 n % 
Relative Parity Number     
First live birth 15,743 73.81 
Second live birth 4,980 23.35 
Third live birth 569 2.67 
Fourth or higher 38 0.17 
Average relative parity 1.3 - 
Delivery Type 
Vaginal delivery 13,030 65.65 
Caesarian delivery 6,818 34.35 
Provider Type at Delivery 
OB/GYN 16,399 82.6 
Family Medicine 291 1.47 
CNM 27 0.14 
Pediatrics 207 1.04 
Other*  2,924 14.7 
*85% of Other denoted as “Multispecialty Practice” 
Residency Affiliation     
OB/GYN Residency Site 2,106 10.6 
Delivery Facility Type 
Hospital 19,143 99.3 
Birthing Center 120 0.62 
Emergency Room 13 0.07 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   52 
Table 3.4 Standardized differences in means of IPTW covariates  
 Unweighted Mean Weighted Mean 
Standardized 
Difference 
Location of Delivery    
Hospital  0.9899 0.9993 0.1992 
Birthing Center 0.0061   
Emergency Room 0.0040 0.0007 0.3164 
County of Residence 
Number 56.8878 58.1095 9.8750 
Provider Type at Delivery    
OB/GYN 0.8171 0.8374 3.5486 
Family Medicine 0.0143 0.0087 0.2235 
CNM 0.0013   
Pediatrics 0.0097 0.0094 0.8897 
Other Specialty 0.1576 0.1446 3.4529 
Insurance Membership Classification   
Child 0.0181 0.0179 1.8473 
Spouse 0.3935 0.3925 5.1390 
Subscriber 0.5882 0.5893 4.6019 
Other 0.0001 0.0003 0.0758 
Age on Delivery 31.8900 31.7367 2.0069 
Relative parity 1.4244 1.3450 2.1469 
White % 73.2311 73.1471 1.5010 
Black % 18.1975 18.2962 5.8002 
Native American/American 
Indian % 0.8704 0.8890 9.0207 
Asian % 2.5897 2.5680 6.5454 
Native Hawaiian/Pacific 
Islander % 0.0447 0.0438 9.2136 
Hispanic (all races) % 8.3343 8.3192 7.2828 
Women over 25 with no 
HS degree/GED % 7.0008 7.0620 5.1971 
Rural 0.1198 0.1206 1.4663 
 
Table 3.5 Method of postpartum contraceptive initiated 
 n %   
Non-use 7,447 34.91 Among Contraceptive Users Only 
Pills 7,968 37.36 57.39 SARC: 61% 
Injectable 169 0.79 1.22 
Ring 330 1.55 2.38 
Implant 231 1.08 1.66 LARC: 28.7% 
Hormonal 3,404 15.96 24.52 
Copper 349 1.64 2.51 
Permanent Sterilization 1,432 6.71 10.31 Permanent: 10.3% 
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Table 3.6 Contraceptive initiation patterns 
 n % 
Time to First Contraceptive after live birth  
Within 3 months 9,047 81.32 
4-6 months 1,225 11.01 
7-9 months 497 4.47 
10-12 months 356 3.2 
Average days to initiation, by delivery type  
Vaginal Delivery 169.81  
Caesarian Delivery 275.18  
Average days to initiation, by method  
Pills 180.02  
Injectable 214.65  
Implant 184.78  
Ring 312.34  
Hormonal IUD 162.38  
Copper IUD 149.68  
Permanent sterilization 529.03  
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Table 3.7 Average marginal effect of initiating contraceptive within 3, 6 and 12 
months postpartum 
n=11558       
 2SRI IPTW 
 3 mos. 6 mos. 12 mos. 3 mos. 6 mos. 12 mos. 
Residency 
affiliation (ref: 
non-residency 
affiliation) 
-0.0708* -0.0597** -0.025 -0.0134 -0.00216 0.00505 
[-0.130,-0.0118] [-0.101,-0.0185] [-0.0574,0.00737] [-0.0508,0.0241] [-0.0315,0.0272] [-0.0151,0.0252] 
Family 
Medicine (ref: 
OB/GYN) 
-0.0317 -0.0202 -0.0065 0.0303 -0.0222 -0.00359 
[-0.125,0.0611] [-0.105,0.0649] [-0.0650,0.0520] [-0.106,0.166] [-0.129,0.0850] [-0.0872,0.0800] 
Pediatrics (ref: 
OB/GYN) 
0.0557 0.00989 0.0228 0.0541 -0.00652 0.0278 
[-0.0106,0.122] [-0.0520,0.0718] [-0.0144,0.0600] [-0.0336,0.142] [-0.0736,0.0606] [-0.0311,0.0867] 
Other 
specialties (ref: 
OB/GYN) 
0.0262* 0.0116 -0.000234 0.0343 0.00904 -0.00154 
[0.00218,0.0502] [-0.00835,0.0315] [-0.0144,0.0140] [-0.00464,0.0733] [-0.0199,0.0380] [-0.0213,0.0182] 
Rural 
community 
(ref: urban 
community) 
0.00932 0.00628 0.00117 0.0645 0.0681** 0.0348* 
[-0.0160,0.0346] [-0.0136,0.0262] [-0.0141,0.0164] [-0.00960,0.139] [0.0249,0.111] [0.00572,0.0638] 
Age on 
delivery 
0.0254*** 0.0158* 0.00972* 0.0317 0.00497 0.00503 
[0.0105,0.0403] [0.00376,0.0278] [0.000454,0.0190] [-0.000915,0.0644] [-0.0216,0.0315] [-0.0112,0.0213] 
Relative parity  
0.0193** 0.0105 0.00585 -0.00589 0.00743 0.00624 
[0.00654,0.0321] [-0.000551,0.0216] [-0.00279,0.0145] [-0.0346,0.0228] [-0.0142,0.0290] [-0.00821,0.0207] 
Caesarian 
section (ref: 
vaginal 
delivery) 
-0.0477*** -0.0458*** -0.0397*** -0.0242 -0.0363* -0.0227* 
[-0.0660,-0.0294] [-0.0600,-0.0317] [-0.0512,-0.0282] [-0.0606,0.0121] [-0.0654,-0.00718] [-0.0436,-0.00187] 
Residual 0.0622 0.0655** 0.0314    
[-0.00464,0.129] [0.0191,0.112] [-0.00552,0.0684]    
[95% confidence intervals in brackets] 
* p<0.05, ** p<0.01, *** p<0.001 
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Table 3.8 Average marginal effect of initiating type of contraceptive (multinomial); 
base outcome non-use 
 SARC LARC Permanent 
Residency affiliation (ref: 
non-residency affiliation) 
-0.0307 0.312 0.0697 
[-1.140,1.078] [-0.903,1.526] [-3.614,3.753] 
Family Medicine (ref: 
OB/GYN) 
-0.725** -0.35 -0.788 
[-1.251,-0.198] [-0.780,0.0803] [-2.393,0.817] 
Pediatrics (ref: OB/GYN) -0.294 -0.103 -0.421 [-0.835,0.248] [-0.679,0.472] [-2.248,1.405] 
Other specialties (ref: 
OB/GYN) 
0.109 0.0297 1.598*** 
[-0.196,0.413] [-0.250,0.310] [0.701,2.495] 
Age on delivery 0.0722 -0.0987* 0.264* [-0.00459,0.149] [-0.180,-0.0172] [0.0629,0.464] 
Relative parity  -0.374*** -0.166*** 0.582*** [-0.432,-0.316] [-0.233,-0.0979] [0.427,0.736] 
Rural community (ref: 
urban community) 
0.051 0.139 0.0339 
[-0.107,0.209] [-0.0375,0.316] [-0.440,0.508] 
Caesarian section (ref: 
vaginal delivery) 
-0.033 -0.204*** 0.597*** 
[-0.111,0.0452] [-0.294,-0.115] [0.384,0.811] 
First stage residual -0.052 -0.438 -1.106 [-1.223,1.119] [-1.723,0.848] [-4.941,2.729] 
[95% confidence intervals in brackets]   
* p<0.05, ** p<0.01, *** p<0.001   
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Table 3.9 Average marginal effect of initiating a LARC  given initiation of any 
non-permanent method within 12 months postpartum 
n=10297   
 2SRI IPTW 
Residency affiliation (ref: 
non-residency affiliation) 
0.0414 0.00577 
[-0.0218,0.105] [-0.0504,0.0619] 
Family Medicine (ref: 
OB/GYN) 
0.136* 0.253** 
[0.0121,0.261] [0.101,0.405] 
Pediatrics (ref: OB/GYN) 0.0431 0.071 [-0.0495,0.136] [-0.0231,0.165] 
Other specialties (ref: 
OB/GYN) 
-0.0134 -0.0179 
[-0.0428,0.0159] [-0.0691,0.0333] 
Age on delivery -0.0363*** -0.000155 [-0.0541,-0.0185] [-0.000786,0.000476] 
Relative parity  0.0482*** 0.0398** [0.0343,0.0621] [0.0120,0.0676] 
Rural community (ref: urban 
community) 
-0.000154 0.0959 
[-0.0320,0.0317] [-0.0287,0.221] 
Caesarian section (ref: 
vaginal delivery) 
-0.0275** -0.0195 
[-0.0479,-0.00718] [-0.0711,0.0320] 
Residual -0.0625  [-0.139,0.0142]  
[95% confidence intervals in brackets]  
* p<0.05, ** p<0.01, *** p<0.001  
 
Figure 3.1 Sample Design 
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  with	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Figure 3.2 Instrumental Variable for Receiving Care from an OB/GYN residency affiliated 
provider 
 
Distance from ZIP of residence to 
closest OB/GYN residency program 
(Z)
Reciept of care from a 
provider/clinic associatied with an 
OB/GYN residency program (X)
Postpartum contracerptive 
initiation (Y)
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CHAPTER 4: THE EFFECT OF MATERNITY CARE PROVIDER SPECIALTY, 
RESIDENCY AFFILIATION, PATIENT RURALITY AND POSTPARTUM 
CONTRACEPTIVE METHOD ON SHORT INTERPREGNANCY INTERVALS 
 
Overview 
Objective: To determine if healthcare provider characteristics, such as specialty and residency 
affiliation, and type of postpartum contraceptive used are associated with short interpregnancy 
intervals among women with multiple births during the study period. 
Methods: We used administrative claims from a large, private insurer merged with ZIP code-
level sociodemographic data from the Census. Our sample included only women with at least 
two live births during the study period. We used a two-stage residual inclusion model to 
determine how provider specialty, provider association with an obstetrics and gynecology 
residency program and the type of postpartum contraceptive initiated affected the probability of 
having a short interpregnancy interval. A short interpregnancy interval was defined as a 
subsequent live birth within 27 months of a previous live birth.  
Results: There were 4,298 women in the sample who had at least two live births during the study 
period. Among women with subsequent live births, nearly 40% occurred within 27 months of a 
previous delivery. The mean interpregnancy interval was 33.1 months but varied by postpartum 
contraceptive choice (unadjusted means of 27.9 months for non-use, 35.2 months for short-acting 
reversible contraceptives and 41.5 months for long-acting reversible contraceptives). Compared 
to women who did not use an observable contraceptive, there was no significant effect on having 
a short interpregnancy interval among women who used a short-acting reversible method within 
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12 months postpartum. Women who initiated a long-acting reversible method within 12 months 
postpartum were 54.2 percentage points less likely to have a repeat birth within 27 months as 
compared with women who used a short-acting reversible contraceptive (p<.01). 
Conclusions: Among women with continuous insurance coverage during the postpartum period, 
short interpregnancy intervals were common at nearly 40% of all live births. Controlling for 
provider specialty and residency affiliation, the facility where she received care, and the 
demographics of the area in which she lives, the strongest predictor of whether she will have a 
short birth interval is the type of contraceptive she uses in the postpartum period.  These findings 
support expanding LARC utilization in the postpartum period to prevent short interpregnancy 
intervals.  
Key Words: interpregnancy intervals, interpregnancy spacing, postpartum contraception, long-
acting reversible contraception 
 
Introduction/Background 
Despite the evidence of associated poor health outcomes, short interpregnancy intervals –
births spaced less than 27 months apart - are common in the United States. In 2015, analysis of 
the National Survey of Family Growth and birth records determined that among the second or 
higher order pregnancies, 35% occurred within 18 months of a previous pregnancy(92). Short 
interpregnancy intervals are associated with poor outcomes for women and infants including 
eclampsia (10,11), anemia (12–14), uterine rupture (15–17), third trimester bleeding (12), 
premature membrane rupture (10,18), puerperal endometriosis (12,18),  placental previa (19), 
and maternal death (12,20,21), low birthweight, preterm birth (18,20–27), small for gestational 
age (18,22,24,26,27), intrauterine growth restriction (28), stunting (29–33), underweight, low 
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height for age, low weight for height (30,33–37), miscarriage (20,38), fetal death (21,38–40), and 
neonatal, infant and early childhood mortality (20,21,33,38–40). Preterm birth, low birthweight 
and small-for-gestational age are all associated with both poor proximal and long-term birth 
outcomes for infants including physiological malformations, respiratory problems, sensory 
deficits, cognitive development delays and death (41,42). 
Given these findings and the high prevalence of short interpregnancy intervals, the 
American Congress of Obstetricians and Gynecologists recommends women in the United States 
have an interpregnancy period no less than 18 months citing increased risks of preterm birth, low 
birth weight and small-for-gestational age (44). The Centers for Disease Control and Prevention 
identified the reduction of short interpregnancy birth intervals as a priority area by proposing a 
national reduction of 10% as a Healthy People 2020 objective (5). Much of the existing research 
describes the attributes of women with short interpregnancy intervals, focusing on insurance 
status and maternal factors such as age, race and ethnicity. This study will expand the literature 
by integrating attributes of the providers and healthcare settings as well as postpartum 
contraceptive initiation patterns as potential factors in predicting short interpregnancy intervals.  
In our study, we will focus on women who had at least two live births during the study 
period. We will test how contraceptive use practices, as well as provider characteristics, affect 
the probability of having a short interpregnancy interval to the next live birth. Our previous 
findings showed that maternity care provider affiliation with an OB/GYN residency program did 
not increase a woman’s probability of initiating postpartum contraceptives nor did it affect her 
initiation of a long-acting reversible method.  However, we did observe that women who 
received maternity services from family medicine providers were 13.6 percentage points more 
likely to use a long-acting reversible contraceptive as compared with women who received care 
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from an OB/GYN. In this study, we will test whether a woman’s maternity care provider 
specialty, affiliation to an OB/GYN residency program or the type of non-permanent 
contraceptive used (long-acting reversible verses short-acting reversible) affects whether or not a 
woman will have a short interpregnancy interval to her next live birth.   
We hypothesize that women who received maternity care from an OB/GYN provider or a 
provider affiliated with an OB/GYN residency program will be less likely to have a short 
interpregnancy interval. We also hypothesize that among women who initiated a non-permanent 
contraceptive method within 12 months of delivery, women who initiated a long-acting 
reversible method will be less likely to have a short interpregnancy interval as compared with 
women who initiated a short-acting reversible method. 
 
Methods 
Data 
 This study used professional, facility and pharmaceutical administrative claims from a 
large, private insurer in North Carolina. The professional and facility claims contained 
information on diagnoses and procedures as well as information on providers such as their name, 
specialty, place of business, and National Provider Identifier (NPI). Provider specialty was 
denoted as the primary specialty associated with a provider’s NPI. Table 4.1 defines the provider 
specialty groups used in analysis that primarily included Obstetricians/Gynecologists and Family 
Medicine providers. Our data comes from an insurance company that uses global billing for 
maternity care services. The global billing codes allowed us to observe in claims the provider or 
practice who provided prenatal, labor and delivery and postpartum services. For this analysis, we 
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used the provider associated with the prenatal services as the designated provider for the 
pregnancy. 
The pharmaceutical claims provided the name of the drug filled, dosage and refill status. 
In addition to claims, we also used a membership file that provided information on the insured 
person including date of birth, ZIP code of residence, employment status and insurance coverage 
information.  Due to the limited individual level characteristics included in the membership file, 
we also used ZIP code level demographics from the 2010-2014 5-Year Census’ American 
Community Survey such as race/ethnicity proportion, poverty indicators and educational 
information. Finally, we determined each ZIP code’s rurality status using the Rural Urban 
Commuting Area (RUCA) codes (82).The RUCA classifications include four groups: urban, 
large rural, small rural and isolated rural. For analysis, we collapsed all non-urban categories into 
a single rural indicator due to small sample sizes in the individual rural categories.  
 To systematically classify the claims into meaningful diagnoses and procedure groups, 
we used the Multi-Level Clinical Classification Software (CCS) for ICD-9-CM developed by the 
Healthcare Cost and Utilization Project at the Agency for Healthcare Research and Quality(84).  
 
Key Measures and Definitions 
Among the key measures integral to this study were interpregnancy interval, short 
interpregnancy interval, and contraceptive type used in the postpartum period. For this study, the 
interpregnancy interval is defined as the time in months from a live birth to the next live birth. A 
short interpregnancy interval is defined as an interpregnancy interval less than 27 months. We 
restricted our analysis to live birth-live birth intervals for several reasons. First, our dependent 
variable- short interpregnancy interval- is dependent upon a reliable indicator of time. In the 
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absence of date of conception data, we relied on the terminal point of a pregnancy to measure 
estimate conception. As spontaneous abortions, induced abortions, and fetal deaths can occur at 
many points during gestational development, we would introduce up to 20 weeks of 
measurement error by including non-live births in the sample. Secondly, much of the existing, 
nationally represented research on interpregnancy intervals has used live birth-live birth 
estimates as it is recorded on the birth record. While the National Survey of Family Growth 
(NSFG) includes estimates for non-live birth terminal events, recent publications comparing 
NSFG and birth record data have focused exclusive on live birth intervals. Finally, we know our 
sample included women who did not have insurance coverage for induced abortions but do not 
know what proportion of the total this group represents. For such reason, we used the most 
conservative measure, live birth to live birth, to estimate interpregnancy interval spacing. 
Contraceptive type is defined as non-use (no evidence of prescription contraceptives), 
short-acting reversible contraceptive (pills, patch, ring, injectable), long-acting reversible 
contraceptive (intrauterine device or subdermal implant), or permanent (tubal ligation or 
occlusion). In this study, we primarily focus on the differences between the short-acting 
reversible and long-acting reversible methods. We also used provider specialty and affiliation 
with an OB/GYN residency program throughout our analysis. The provider associated with the 
birth interval was the one for whom the global maternity payment was made for the first birth in 
the interpregnancy interval pair; this provider was responsible for prenatal and postpartum care 
and sometimes delivery. In this study, we classified specialty into the five most common groups: 
OB/GYN, family medicine, certified nurse midwife, pediatrics and other/multispecialty practice. 
We also denoted physicians as affiliated with an OB/GYN residency site if they practiced at a 
facility associated with one of Graduate Medical Education accredited residency programs in 
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Obstetrics and Gynecology. Finally, we used ZIP code demographic indicators as controls in our 
model including the percent of a ZIP code population identifying with the major racial groups, 
Hispanic ethnicity, and women over 25 years of age without a high school diploma or equivalent 
degree. Table 4.1 below provides additional definitions and explanations for how we developed 
our key measures. 
 
Sample 
 Our sample included women between the ages of 10-60 with at least two live births 
during the study period of January 2008-September 2014. All women in the sample retained 
insurance coverage for at least 60 months following their first live birth with no more than 3 
months of lapsed coverage. We removed births from our sample if there was not at least 36 
month follow up period to protect against time censoring.  As 12% of women have more than 
two live births during the study period, we will use adjusted standard errors due to multiple 
observations per woman.  The final analytic sample included 4,298 unique women and 4,793 
interpregnancy intervals. The unit of analysis for estimation models is the interpregnancy 
interval between two live births.  
 
Analysis 
We modeled the probability of a woman having two live births within 27 months of one 
another using causal techniques to control for the effects of previous provider type and affiliation 
with an OB/GYN residency program as well as the type of postpartum contraceptive used. We 
anticipated that both receiving care from a residency provider and the method of contraception 
used in the previous postpartum period are endogenous to our outcome. As such, we constructed 
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a two-stage residual inclusion (2SRI) model to address potentially endogenous variables and 
measure the causal pathway on the probability of having a short interpregnancy interval.   
 To address the endogeneity of both previous provider residency affiliation as well as 
previous postpartum contraceptive method, we constructed two first-stage models. Numerous 
factors influence a woman’s decision to receive care in a particular facility including proximity, 
existing relationship with the practice, type of provider, degree of pregnancy risk, and other 
unobserved factors (85). First, we use an instrumental variable (IV) in a linear probability model 
to address the endogeneity and unobserved variation of women’s decision to receive maternity 
care from a provider associated with an OB/GYN residency program. Following prior work, we 
used the distance (in miles) from the centroid of a woman’s residential zip code to the address of 
the closest residency program as an instrument for her choice to receive residency-affiliated 
care(86–88). Figure 4.1 shows the proposed instrumental pathway. We tested the strength of the 
instrument using a Wald test which yielding an F-statistic of 25.96 with p<.01 indicating a strong 
instrument.  
 We then constructed a multinomial logit model addressing the endogeneity of the method 
of contraceptive used in the postpartum period after the first live birth. The dependent variable 
included non-use (women with no observable contraceptive claim within 12 months of delivery), 
short-acting reversible contraceptive use and long-acting reversible contraceptive use.  To do so, 
we constructed an instrument for a woman’s initiation of a long-acting reversible contraceptive 
or short-acting contraceptive based upon her previous providers prescribing preference; the 
instrumental pathway is shown in Figure 4.2. This instrumental variable approach has previously 
been successful when applied to similar other areas such as prescribing preferences of Cox-2 
inhibitors (93). We calculated a provider’s prescribing preference as the number of long-acting 
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reversible contraceptives prescribed divided by all non-permanent contraceptives prescribed by 
providers within the sample. For example, if Provider A had ten women in the sample and three 
began a LARC and seven begin a SARC in the postpartum period, that provider’s LARC 
prescribing preference is 3/10 or .33.  We excluded providers who only had one contraceptive 
claim within the data. The mean LARC prescribing preference for the sample was 4.6% with a 
minimum of zero and a maximum of 100%. We tested the strength of the instrument based on 
prescribing preference using a Wald test. For the SARC dependent variable, the F-statistic was 
10.38 (p<.01) while it was 32.22 (p<.001) for the LARC dependent variable indicating a strong 
instrument in both branches of the model.  
 We calculated an indicator of whether or not a woman had a second live birth within 27 
months of previous delivery. Within administrative claims, it is difficult to measure the time 
point of conception given the significant variation in when women first realize they are pregnant 
and when are seen for their first prenatal care visit. As such, we selected the terminal point in the 
pregnancy, the live birth, to determine healthy birth intervals. To do so, we measured the days 
from previous delivery to current delivery. To allow for slight variations in gestational age at 
birth, we counted backwards using a 37-week gestational period; this allowed for deliveries that 
occurred prior to 40 weeks’ gestation but were conceived after 18 months postpartum to be 
considered as having a healthy interpregnancy interval. We will hereafter describe short 
interpregnancy intervals as those with less than 27 months between deliveries.  Figure 4.3 shows 
the timeline of events and measurement points.  
In the second stage of the model, we used a logistic regression model of the dependent 
variable indicating a short interpregnancy interval. For the 2SRI model, we included key 
covariates such as previous provider type and type of delivery, control variables for a woman’s 
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ZIP code demographics (such as racial and ethnic group mix and high school educational 
attainment) as well as both the endogenous variables from the first stage (previous provider 
associated with a residency program and type of contraceptive used in previous postpartum 
period) and the residuals from both stage one models. We used bootstrapped clustered errors by 
unique women to adjust for women who had multiple interpregnancy intervals within the dataset.  
 
Sensitivity Analysis 
In sensitivity analyses, we tested if there was a potential interaction between provider 
specialty type and the type of contraceptive a woman used and an interaction between the time at 
which a woman initiated postpartum contraceptives and the type of contraceptive she used. We 
also conducted sensitivity analysis using a 26- month interpregnancy interval threshold to allow 
for up to four weeks of prematurity. 
 
Results 
The age at first delivery ranged from 16 to 55 with a mean of 32.4 years old; the median 
age was 32.3. The sample was predominantly concentrated in urban areas (89.2%) following by 
large rural (7.1%), small rural (1.8%) and isolated rural (1.99%) per RUCA classification of 
residential zip code. For analytic purposes, we grouped all non-urban areas together as rural. 
Among the subsequent births (the unit of analysis), approximately 88.8% were a woman’s 
second observed live birth during the study period, 10.5% the third, and < 1% the fourth or 
higher; this indicates 88.8% of women only contributed one interpregnancy interval to the 
sample. The average relative parity at time of first live birth in the interval pair was 2.12.  Of 
subsequent live births in the sample, 64.6% were delivered vaginally after a previous vaginal 
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delivery and 2.3% were delivered vaginally after previous caesarian. Among those delivered via 
caesarian, 26.1% were repeat caesarians while 6.99% were following a previous vaginal delivery 
(Table 4.3).   
 Of the second births in the interval pair, 81.4% were attended to by an OB/GYN, 1.8% 
by a Family Medicine Provider, 1.5% by a Pediatrician, and .13% by a Certified Nurse Midwife 
(CNM). Additionally, 15.2% of deliveries were attended to by a provider associated with a 
“Multispecialty Practice”; multispecialty practice could denote a variety of provider specialties. 
For further explanation of the multispecialty practice variable, see the data sections of Chapter 3. 
These trends were very similar to the women’s previous provider specialty (Table 4.4).  
 The mean interpregnancy interval was 994 days (33.1 months) and the media was 904 
days (30.1 months). The mean interpregnancy interval varied by the type of contraceptive 
method first used by women. Among women who did not use an observable contraceptive within 
12 months of delivery, the mean interpregnancy interval was 837 days or approximately 27.9 
months (Table 4.5). The mean interpregnancy spacing for women with evidence of using a short-
acting reversible contraceptive was 1057 days (35.2 months), while the mean interpregnancy 
spacing for women with evidence of using a long-acting reversible contraceptive method was 
1244 days (41.5 months). Figure 4.3 shows the distribution of births occurring at various 
postpartum time points by the type of contraceptive used. Of all the subsequent births in the data, 
39.7% occurred within 27 months of a previous live birth (Table 4.5).  Among births to women 
who did not use any observable form of contraception within 12 months of delivery, 55.9% of all 
subsequent births occurred within 27 months postpartum.  
 Table 4.6 shows the results of the first stage models. Table 4.7 shows the results of the 
two-stage residual inclusion model estimating the probability of having a short interpregnancy 
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interval. The results in Table 4.7 are to be interpreted via the local average treatment effect 
(LATE) context; this interpretation yields results that represent only those observations which 
were affected by the instrumental variables. For Table 4.7, results should be interpreted within 
the context that these findings are representative of women for whom distance affected provider 
selection and provider’s prescribing preference affected choice of postpartum contraceptive 
method. 
 
A woman’s maternity providers’ affiliation to a residency program and specialty for the 
first live birth of the interpregnancy interval pair did not have a significant effect on having a 
second live birth within 27 months. As hypothesized, there were significant differences in 
interpregnancy intervals by the method of contraceptive used during the previous postpartum 
period.  The mean predicted probability of having a second live birth within 27 months of a 
previous live birth was estimated as 39% across all women in the sample. As compared to 
women who did not use an observable contraceptive method, there was no effect of using a 
short-acting reversible method within 12 months postpartum on having a repeat live birth within 
27 months after controlling for selection bias inherent to use. However, women who initiated a 
long-acting reversible method within 12 months postpartum were 54.2 percentage points less 
likely to have a repeat live birth within 27 months (p<.05) than women who used a short-acting 
reversible method. Additionally, there was no significant effect of living in a rural area or having 
a caesarian delivery at last birth and having a short interpregnancy interval. As is seen in Table 
4.7 as age increased by one year, the probability of an interpregnancy interval of less than 27 
months decreased by eight percentage points (p<001).  
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 In our sensitivity testing, the interactions between provider specialty type and the type of 
contraceptive a woman used did not have significant coefficients. None of the interaction terms 
had a significant coefficient (data not shown). In the model with a shortened interpregnancy 
interval of 26 months allowing for up to 4 weeks of prematurity, results were not meaningfully 
different (data not shown). 
 
Discussion 
 After selecting a sample of women with continuous private insurance coverage and 
controlling for maternal age and relative parity, delivery characteristics and the demographics of 
a woman’s residential zip code, there was a large statistically and clinically significant 
association between a woman’s postpartum contraceptive method and short interpregnancy 
intervals. The type of provider she saw for her initial pregnancy (OB/GYN, Family Medicine, 
Pediatrics or Other Specialty) and the provider’s affiliation with an OB/GYN residency program 
had no significant effect on her interpregnancy intervals. This suggests that current messaging to 
women about the importance of healthy interpregnancy intervals may be lacking across all 
specialty types.   
 This research also confirmed that contraceptive initiation within 12 months of delivery 
reduces the risk of short interpregnancy intervals. These findings support expanded utilization of 
LARCs in the postpartum period for women hoping to have another pregnancy while safely 
delaying until the recommended time of conception.  Future research in this area should explore 
additional factors such as desired family size and contraceptive history not observable in claims. 
There is opportunity for mixed methods that could intersect claims data with both patient and 
provider interviews regarding the challenges and barriers to LARC initiation. One known area of 
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improving LARC access is ensuring that women have access to providers trained in the insertion 
of intrauterine devices or implants; our data did not include any indicators regarding a provider’s 
ability to insert LARCs. An area of opportunity for the insurance provider is to determine what 
proportion of its current maternity care providers do not have this training and consider funding 
expanded training opportunities for in-network providers. Additionally, the insurer could also 
provide a comprehensive list of providers and facilities with currently trained staff to support 
service referrals for women wishing to initiate a LARC. 
 One of the more interesting findings is that among our sample of women with stable, 
continuous insurance coverage, the probability of short interpregnancy intervals was higher than 
observed in previous national estimates(94). While this sample contains only women with 
private insurance coverage, and therefore cannot be extrapolated to represent national estimates, 
our findings offer new insights into the potential relationship between insurance coverage and 
interpregnancy intervals. Previous literature has suggested that one potential reason for short 
interpregnancy intervals is that women may have inconsistent insurance following a birth (due to 
limited coverage via Medicaid coverage for pregnant women or gaps in coverage caused by 
women leaving the workforce)(94–97). Our estimates for short interpregnancy intervals among 
women with consistent insurance coverage, are slightly higher than the most recent national 
statistics. First, the women in our sample are older than the general population of women giving 
birth as well as more likely to be employed; this may suggest women in our sample may have 
delayed childbearing for educational and professional opportunities. As pregnancy related risks 
increase with maternal age, our sample of women may be balancing the risks of short 
interpregnancy intervals with those associated with advanced maternal age to achieve ideal 
	   72 
family size. Future research could explore the risk trade-offs and outcomes from women who 
may face opposing recommendations.   
Given that all women in the sample had some access to clinical services as well as 
contraceptives, we could also hypothesize that the perceived risk of poor birth outcomes caused 
by short interpregnancy intervals may not be high enough to deter women from short birth 
intervals. These findings suggest further research on the messaging women receive in the 
prenatal and postpartum period on healthy interpregnancy spacing. It may be particularly 
relevant to study how provider’s counseling and recommendations for healthy interpregnancy 
intervals differ by age as women must balance the risks of short interpregnancy intervals with the 
risks advanced maternal age. 
 
Limitations 
 This study has several limitations to consider. In the absence of a randomized control 
trial, we used instrumental variables to address the known endogeneity of provider and 
contraceptive method selection. While these instruments are useful, there may be other 
unobservable differences across women in the sample that are likely associated with provider 
selection, contraceptive initiation, and interpregnancy intervals that our models could not 
address.  
As our data source was administrative claims, we can only measure those services that 
reimbursed by the insurance company. Our analysis was not able to account for the use of 
condoms, natural family planning or partner vasectomy as a method of contraception thereby 
likely over-estimating the number of women classified as not using any contraceptive method 
and potentially biasing our estimates.  If the true risk of a short interpregnancy interval is 
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actually higher for women not using any method (masked by some of our non-use sample 
actually using an unobservable method), our model under-estimates the effect of SARCs and 
LARCs on reducing short interpregnancy intervals. Additionally, we did not have access to many 
individual level demographic characteristics and therefore relied on attributes of zip codes, 
which may not be representative of individual members’ characteristics. While these indicators 
are useful control variables, interpreting these population level attributes as though they 
represent the individuals is an ecological fallacy and will bias the interpretation of the models. 
As such, our models included these covariates but did not directly interpret any of the 
coefficients or effects associated with them.  
Because we are unable to precisely estimate the date of conception, we used claims 
associated with labor and delivery in order to estimate the time from birth until the next 
pregnancy. Given the heterogeneity of when women realize they are pregnant and how quickly 
they enter prenatal care, we used the labor and delivery claim as the referent point. While we 
relaxed the healthy gestational age to include any delivery greater than 36 weeks, we may have 
overestimated short interpregnancy intervals among women who had preterm births at earlier 
gestations as the maternal claims did not include an indicator for birth outcomes such as 
gestational age or NICU admission. Future analysis on interpregnancy intervals could integrate 
the infant claims and therefore better estimate gestational age. Additionally, we did not include 
spontaneous abortions, fetal deaths, or induced abortions in our analysis thereby underestimating 
postpartum pregnancies.  
Finally, the requirement of 60 months of continuous private insurance coverage may limit 
the generalizability of our study to other populations such as women using Medicaid or those 
who have recently enrolled in insurance programs via the Affordable Care Act marketplaces.  
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Conclusions 
 Among women with consistent insurance coverage during the postpartum period, short 
interpregnancy intervals were common, exceeding previous national estimates. Controlling for 
characteristics associated with her provider, the facility where she received care, and the 
demographics of the area in which she lives, the strongest predictor of whether a woman would 
have a short birth interval is the type of contraceptive she uses in the postpartum period.  Women 
using a long-acting method versus a short-acting method were significantly less likely to have a 
short interpregnancy interval to their next birth. Given the mounting evidence supporting the use 
of long-acting reversible contraceptives in the postpartum period and the current 
recommendations from the American Congress of Obstetricians and Gynecologists (45), these 
findings demonstrate that postpartum contraceptives are a critical component to preventing short 
birth intervals and that continued emphasis should be placed on the value of long-acting 
methods.    
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Tables and Figures 
Table 4.1 Key Measures and Definitions 
Interpregnancy Intervals 
Interpregnancy interval The time (months) between two live births 
Short interpregnancy 
interval An interpregnancy interval of <27 months 
Contraceptive Use  
Contraceptive initiation 
The first postpartum medical or pharmaceutical claim associated with 
beginning contraceptives; e.g. CPT code 58300- Insertion of an 
intrauterine device or prescription filled for oral contraceptive method 
Contraceptive non-use No recoded claim for any contraceptive method within 24 months of delivery 
Short-acting reversible 
contraception Includes hormonal pills, patch, vaginal ring and injectable 
Long-acting reversible 
contraceptive  
Includes both the hormonal and copper intrauterine devices as well as the 
subdermal implant 
Permanent sterilization Includes both tubal ligation and occlusion 
Contraceptive type Mutually exclusive categories of non-use, SARC, LARC, permanent 
Provider 
Characteristics  
Provider Specialty 
Designation 
The specialty code of the provider who received the payment for the 
maternity care 
Provider Specialty 
For this study, we categorized providers into the five largest groups: 
Obstetricians and Gynecologists, Family Medicine, Certified Nurse 
Midwives (CNM), Pediatrics and Multispecialty Practice. During 
analysis, we did not interpret the findings associated with women seen 
by CNMs due to a very small sample. Additionally, Multispecialty 
Practice designation did not provide sufficient information for 
comparison with our referent group, OB/GYNs; it remained in the model 
as a covariate however could not be meaningfully interpreted given the 
lack of detailed information. 
Residency Affiliation 
Using the Accreditation Council for Graduate Medical Education 
directory, we identified those hospitals and practices associated with an 
OB/GYN residency training program. We allocated all providers at that 
site as "affiliated" to an OB/GYN residency program, regardless of 
specialty.  
Distance to nearest 
OB/GYN residency 
program 
The distance (miles) from a woman's ZIP code centroid to the nearest 
accredited OB/GYN residency program; for multi-clinic practices, the 
central hospital was used as the end point 
Provider's LARC 
prescribing preference 
Among all non-permanent contraceptive prescriptions attributed to a 
provider, the proportion that are for a long-acting reversible 
contraceptive 
Demographic Characteristics 
Maternal age A woman's age on the day of delivery (years) 
Group health plan Binary indictor of whether a woman was enrolled in a group based insurance plan or individual plan 
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Rural Residential zip code with RUCA classification of large rural, small rural or isolated rural 
Relative parity The number of live births a woman has within the data time frame 
White % The percent of a zip code identifying as White per Census estimates 
Black % The percent of a zip code identifying as Black per Census estimates 
Native 
American/American 
Indian % 
The percent of a zip code identifying as Native American/American 
Indian per Census estimates  
Asian % The percent of a zip code identifying as Asian per Census estimates 
Native Hawaiian/Pacific 
Islander % 
The percent of a zip code identifying as Native Hawaiian/Pacific Islander 
per Census estimates 
Hispanic % The percent of a zip code identifying as Hispanic per Census estimates; includes ALL races 
Females over 25 without 
high school degree/GED 
% 
The percent of women in a zip code over age 25 without a high school 
diploma or GED equivalency per Census estimates 
 
 
Table 4.2 Attributes of women in sample 
 n % 
Unique women in sample 4298 - 
Number of discrete interpregnancy intervals 4793 - 
Age at time of event (mean) 32.4 - 
Insurance Membership Classification   
Subscriber 2,593 54.1 
Spouse 2,130 44.44 
Child 70 1.46 
Geographic Attributes of ZIP Code   
Urban 4,275 89.19 
Large rural 338 7.05 
Small rural 85 1.77 
Isolated rural 95 1.98 
 
 
Table 4.3 Attributes of live births in sample  
 n % 
Relative Parity Number   
Second live birth 4,254 88.75 
Third live birth 504 10.52 
Fourth or higher 34 0.73 
Average relative parity 2.12  
Delivery Type   
Vaginal delivery after  vaginal delivery 3,118 64.6 
Vaginal delivery after caesarian  112 2.32 
Caesarian delivery after vaginal  337 6.98 
Caesarian delivery after caesarian 1,259 26.1 
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Table 4.4 Provider, Residency and Facility Characteristics of Births 
 Subsequent (2nd)  Pregnancy Previous (1st) Pregnancy 
 n % n % 
Provider Specialty     
OB/GYN 3,903 81.43 3,973 82.89 
Family Medicine 85 1.77 74 1.54 
CNM 6 0.13 7 0.15 
Pediatrics 73 1.52 48 1 
Other specialty 726 15.15 691 14.42 
Residency Affiliation     
OB/GYN Residency Site 518 10.81 515 10.74 
Delivery Facility Type     
Hospital 4,600 99.03 4,589 99.2 
Birthing Center 41 0.88 35 0.76 
Emergency Room 4 0.09 2 0.04 
 
 
 
Table 4.5 Interpregnancy Interval Characteristics  
 n % 
<12 months 95 1.98 
<18 months 451 9.42 
<24 months 930 19.42 
<30 months 946 19.75 
<36 months 721 15.05 
<42 months 523 10.92 
<54 months 714 14.91 
<60 months 179 3.74 
5 years + 231 4.82 
Mean time to next delivery  944 days (33.1 months) 
Mean time to next delivery by previous method of contraceptive 
 n mean 
Non-use 1735 837 days (27.9 months) 
SARC 2282 
1057 days (35.2 
months) 
LARC 586 1244 day (41.5 months) 
Short interpregnancy intervals by previous method of contraception 
 n % 
Non-use 970 55.91 
SARC 738 32.34 
LARC 100 17.06 
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Table 4.6 First stage models     
First Stage Models (n=4587) 
Model 1: 
Pr(Residency 
Program) 
Model 2: Pr(Contraceptive Type) 
 
 Coefficient Coefficient on SARC Choice 
Coefficient on 
LARC Choice 
Distance to closest residency -0.00232*** - - 
[-0.00321,-0.00143]   
LARC provider prescribing 
preference 
- -0.0748** 0.211*** 
 [-0.123,-0.0269] [0.138,0.284] 
Family Medicine (ref: 
OB/GYN) 
0.205*** -1.355*** -1.007* 
[0.129,0.281] [-1.981,-0.729] [-1.820,-0.193] 
Certified Nurse Midwife -0.00587 -0.771 -0.351 [-0.0253,0.0136] [-2.582,1.040] [-2.634,1.932] 
Pediatrics (ref: OB/GYN) 0.381*** -0.449 -0.656 [0.333,0.429] [-1.102,0.205] [-1.747,0.434] 
Other specialties (ref: 
OB/GYN) 
0.254*** 0.237* 0.0327 
[0.234,0.273] [0.0405,0.434] [-0.258,0.323] 
Age on delivery 0.00721 0.374*** 0.139 [-0.0000234,0.0144] [0.211,0.538] [-0.0884,0.366] 
Relative parity  -0.00632* -0.651*** -0.623*** [-0.0120,-0.000662] [-0.820,-0.482] [-0.900,-0.346] 
Rural community (ref: urban 
community) 
-0.00278 -0.0703 0.0609 
[-0.0311,0.0256] [-0.296,0.155] [-0.258,0.380] 
White % -0.00392 0.0157 -0.0326 [-0.00797,0.000125] [-0.0492,0.0806] [-0.124,0.0588] 
Black % -0.00366 0.013 -0.0288 [-0.00771,0.000386] [-0.0527,0.0788] [-0.121,0.0637] 
Native American/American 
Indian % 
-0.00392 0.0154 -0.0369 
[-0.00807,0.000238] [-0.0541,0.0848] [-0.134,0.0606] 
Asian % -0.000731 0.00511 -0.0572 [-0.00526,0.00380] [-0.0653,0.0756] [-0.158,0.0441] 
Native Hawaiian/Pacific 
Islander % 
-0.0118 0.391 0.24 
[-0.0424,0.0188] [-0.159,0.941] [-0.510,0.989] 
Hispanic % 
-0.00118 -0.0213* -0.0355* 
[-0.00269,0.000330] [-0.0397,-0.00292] 
[-0.0632,-
0.00782] 
Females over 25 without high 
school degree/GED % 
-0.00133 0.0320** 0.0443** 
[-0.00296,0.000300] [0.0123,0.0516] [0.0165,0.0721] 
constant 0.438* -5.367 1.463 [0.0214,0.854] [-12.24,1.506] [-8.181,11.11] 
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Table 4.7 Second stage model   
 Coefficient 
Average  
Marginal Effect 
SARC (ref: non-use) -1.765 -0.387 [-4.905,1.376] [-0.920,0.146] 
LARC (ref: non-use) -2.845 -0.542* [-6.373,0.683] [-1.071,-0.0132] 
Residency affiliation (ref: non-residency 
affiliation) 
0.0032 0.000681 
[-0.292,0.298] [-0.0629,0.0642] 
Family Medicine (ref: OB/GYN) -0.447 -0.0908 [-1.473,0.580] [-0.303,0.122] 
Certified Nurse Midwife 0.251 0.0545 [-1.717,2.220] [-0.322,0.431] 
Pediatrics (ref: OB/GYN) -0.45 -0.0914 [-1.209,0.309] [-0.244,0.0612] 
Other specialties (ref: OB/GYN) -0.0259 -0.0055 [-0.243,0.191] [-0.0556,0.0446] 
Rural community (ref: urban community) -0.00289 -0.000616 [-0.212,0.206] [-0.0474,0.0462] 
Age on delivery -0.387** -0.0825* [-0.670,-0.105] [-0.146,-0.0185] 
Relative parity  0.343 0.073 [-0.149,0.834] [-0.0479,0.194] 
Caesarian section (ref: vaginal delivery) 0.0813 0.0173 [-0.125,0.288] [-0.0308,0.0655] 
White % -0.0647* -0.0138 [-0.128,-0.00174] [-0.0295,0.00197] 
Black % -0.0640* -0.0136 [-0.128,-0.000225] [-0.0296,0.00233] 
Native American/American Indian % -0.0707* -0.015 [-0.137,-0.00387] [-0.0318,0.00168] 
Asian % -0.0772* -0.0164 [-0.147,-0.00753] [-0.0338,0.000969] 
Native Hawaiian/Pacific Islander % -0.549 -0.117 [-1.105,0.00656] [-0.260,0.0258] 
Hispanic % -0.00694 -0.00148 [-0.0304,0.0165] [-0.00721,0.00425] 
Females over 25 without high school 
degree/GED % 
-0.0206 -0.00439 
[-0.0466,0.00527] [-0.0110,0.00218] 
Residual: Residency Affiliation -0.0261 -0.00555 [-0.345,0.292] [-0.0748,0.0637] 
Residual: SARC Use 0.799 0.17 [-2.340,3.939] [-0.575,0.916] 
Residual: LARC Use 0.957 0.204 [-2.571,4.486] [-0.665,1.072] 
constant 14.22***  [7.368,21.08]  
[95% confidence intervals in brackets]   
* p<0.05, ** p<0.01, *** p<0.001   
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Figure 4.1 Instrumental Variable for Receiving Care from an OB/GYN residency affiliated 
provider  
 
Figure 4.2 Instrumental Variable for Contraceptive Choice in Postpartum Period 
 
Figure 4.3 Interpregnancy interval timeline 
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CHAPTER 5: DISCUSSION 
 
Findings 
 Our study has several notable findings that enhance the scientific literature on postpartum 
contraceptive initiation patterns and interpregnancy intervals. We found that receiving maternity 
care from a provider associated with an obstetrics and gynecology residency site did not increase 
a woman’s probability of initiating a postpartum contraceptive. We also found that women who 
received care from a residency affiliated provider were not more likely to use a long-acting 
reversible contraceptive during the postpartum period. While these findings are contrary to our 
initial hypotheses, there are several potential reasons for these results. Providers at residency 
sites represent not only experienced providers teaching new physicians but also those physicians 
in early training; new providers may not have sufficient experience with postpartum 
contraceptive counseling and services to advise women on the importance of preventing short 
interpregnancy intervals.  
In addition to the provider variation, despite having a sample of women with consistent 
private insurance, there may be unobserved differences between women who receive care from a 
residency affiliated provider and those who do not. For example, in many communities, large 
teaching hospitals act as safety-net institutions and may have a riskier patient pool as compared 
with other providers. Additionally, residency affiliated providers may be more likely to practice 
within institutions that have more specialty services for high risk pregnancies. For example, 
women with previous poor birth outcomes or chronic conditions that may make pregnancy 
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dangerous are likely more apt to receive services at facilities with enhanced NICU services or 
maternal and fetal medicine providers; these providers are more likely to be associated with 
teaching/residency sites. These characteristics were not available in our data yet may influence a 
woman’s postpartum contraceptive behaviors as well as interpregnancy spacing may our 
estimates.  
 Our findings also showed that the specialty of a woman’s maternity care provider did not 
affect the timing to postpartum contraceptive initiation or the probability of having a short 
interpregnancy intervals. The only significant relationship between provider specialty and our 
key outcomes was between family medicine providers and long-acting reversible contraceptive 
initiation. While these findings do not support our initial hypothesis that women who receive 
care from obstetricians and gynecologist would have higher postpartum contraceptive utilization, 
higher LARC utilization and fewer short interpregnancy intervals, they still offer additional 
insights into how service delivery systems may or may not affect our key outcomes of interest.  
 Our findings also present new evidence to the field as our sample was drawn from a 
population of women with continuous, private insurance coverage. Much of the previous 
literature on interpregnancy spacing and short interpregnancy intervals has focused on women 
with Medicaid and hypothesized insurance discontinuity was a considerable factor in the high 
incidence of short interpregnancy intervals. Our findings show comparable, and even slightly 
higher, rates of short interpregnancy intervals. While this cannot dispel the hypothesis that 
insurance status is potentially protective against short interpregnancy intervals, it does suggest 
that the relationship may be more complex than simply having any insurance coverage. As 
research continues on this important topic, it will be important to consider the implications of the 
Affordable Care Act and increased access to insurance coverage for women via either Medicaid 
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expansion of the subsidized marketplaces. The demographics of uninsured, publicly insured, and 
privately insured women will continue to shift in the coming years and lend themselves to more 
comprehensive research on what personal characteristics are protective against short 
interpregnancy intervals beyond simply having insurance.   
 
Policy Implications 
 These findings have several potential policy implications for insurers, both private and 
public. As private insurance companies and Medicaid move towards bundled maternity care 
services with global billing codes, there is increased potential to implement quality improvement 
initiatives into routine care. With bundled maternity services, providers receive an agreed upon 
amount for all routine prenatal, labor and delivery, and postpartum care; reimbursement rates 
differ by delivery type with caesarian sections being reimbursed at a higher value due to 
increased costs. Included within the bundled maternity care is the expectation that providers are 
adhering to a standard of care in the postpartum visit which requires postpartum contraceptive 
counseling. However, as the reimbursed amount is previously agreed upon, there may not be 
additional incentives for providers to fully document all services rendered. For example, 
providers may see no added benefit of recording postpartum contraceptive counseling as it will 
not affect the reimbursement. The insurer could implement a strategic quality improvement 
effort that requires providers to certify via a billing modifier code that return to fertility and 
contraceptives have been discussed with women, among other important services included within 
the bundled payment mechanism. 
 In addition to ensuring this postpartum service is being provided, the insurer could 
explore additional targeted interventions for women in the late prenatal and early postpartum 
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period to initiate contraceptives. Women receiving maternity services are a particularly engaged 
consumers of health services; by the end of pregnancy many women are interacting with 
providers nearly weekly. Insurers could work with providers and clinical practices to 
strategically communicate the importance of postpartum contraceptive with women during their 
final prenatal care visits. This could include the use of new media in clinics, revising 
contraceptive counseling practices or using reminder cards. Reminder cards (cards mailed 
directly to patients’ homes to prompt a patient to schedule an important health service) have been 
used successfully to remind patients to return for dental cleaning, breast exams, colonoscopies 
and pap smears.  Practices or the insurer themselves could implement a similar tactic with 
women in the postpartum period indicating that a woman will soon return to fertility and that it is 
an appropriate time to consider contraceptive options. Considering two of the primary reasons 
women stated they did not initiate postpartum contraceptives earlier in the postpartum period 
was not believing they could become pregnant or forgetting given the demands of a new 
infant(9), this may be a potential low-cost intervention that may not substantially burden 
providers.  
 Finally, long-acting reversible contraceptives require specialty training for providers. 
Many of the trainings are proprietary to the manufacturers of the contraceptive devices and can 
be costly to clinical practices. Given the financial burden of unintended pregnancies on insurance 
companies, they may consider providing additional, no-cost training to providers interested in 
providing LARCs to their patients. This may increase the proportion of members relying on 
LARCs in the postpartum period and thereby reduce the incidence of short interpregnancy 
intervals. Additionally, the insurer could also put in place penalties for practices that provide in-
network maternity services without any clinical staff trained in LARC insertions or removals.  
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Limitations 
 These studies had several limitations to consider when interpreting the findings. First and 
foremost, this study was designed to retrospectively use administrative claims data. In the 
absence of a randomized control trial, we used several techniques to adjust for potential selection 
bias and endogeneity in our models. Both two-stage residual inclusion and inverse probability of 
treatment weights are useful to address biases caused by unobserved variants however have their 
limitations. There may be additional unobserved biases associated with selecting a provider 
affiliated with a residency program and the method of postpartum contraceptive initiated that are 
not accounted for in our models.  
 Provider attributes were an important component of this study, namely provider specialty. 
The available claims used the NPI used to bill for services rendered; this number could represent 
a single provider or an entire clinical practice. This may effect how some provider specialties 
were measured and lead to the large number of women seen by “multispecialty providers”.  
Additionally, the inclusion of both individuals and practices in the provider identification 
variable may have also affected how the prescribing preference instrument used in Chapter 3 
functioned.  
 This study also focused on the contraceptive a woman first initiated in the postpartum 
period. We did not measure adherence or method switching, both of which would affect a 
woman’s protection against unintended pregnancy. Additionally, our analysis was limited only to 
those methods which were observed from reimbursement.  Women who were using condoms, 
natural family planning or partner vasectomy to prevent unintended pregnancy are denoted as 
non-users in our analysis. This unobserved variant leads our estimates to be negatively biased 
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and underestimate the effect of long and short-acting reversible contraceptives on short 
interpregnancy intervals. 
 Measuring pregnancy related outcomes in claims data is challenging. Claims does not 
provide an estimated date of conception thereby requiring us to use alternative time points to 
measure the timing of pregnancy. Given the heterogeneity of when women realize they are 
pregnant as well as when they receive their first prenatal care visit, we relied on the terminal 
point in pregnancy as the timing measure and counted backwards to conception. While this 
method is the more stable option, it relies on estimated gestational age. While we relaxed the 
healthy gestational age to include any delivery greater than 36 weeks, we may have 
overestimated short interpregnancy intervals among women who had preterm births at earlier 
gestations as the maternal claims did not include an indicator for birth outcomes such as 
gestational age or NICU admission. Due to the challenges of measuring date of conception in 
claims data, we limited our study to only live births. This lead to underreporting of pregnancies 
as we did not take into account those ending in spontaneous abortion, induced abortion or fetal 
death.  
 Claims data offers limited social and demographics information on members. To control 
for some heterogeneity across women in the sample, we used population level characteristics 
from a woman’s ZIP code of residency. These characteristics may not reflect the actual members 
and therefore bias our estimates.  
 Finally, the requirement on 60 months of continuous private insurance coverage, may 
limit the generalizability of our study to other populations.  
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Areas for Future Research 
 While this project has enhanced the body of literature on postpartum contraceptive 
initiation patterns and interpregnancy intervals, there are still significant opportunities for future 
research. One potential area of opportunity is to further document and assess how women receive 
information on the importance of postpartum contraceptives and healthy interpregnancy 
intervals. This lends itself to a mixed methods approach which could combine insurance claims, 
medical charts and surveys with both women and their providers. While there is some literature 
on the barriers providers face when discussing contraceptives, this study could expand and ask 
not only about the challenges of patient counseling but also those factors that a health system 
could modify such as the provision of additional training, tools for proper reimbursement as well 
as stock issues. For women, additional qualitative information could study how women decide 
on when to begin postpartum contraception as well as assess their perceived risks associated with 
short interpregnancy intervals. Subpopulation analysis could further measure how women of 
make interpregnancy interval decisions while balancing the risks of short interpregnancy 
intervals with the those of advanced maternal age.  
 Additionally, future studies could study how women initiate, adhere, and discontinue 
contraceptives in the postpartum period. While this study exclusively looked at the method and 
timing of a woman’s first postpartum contraceptive method, future studies could examine what 
factors lead to increased adherence of SARCs as well as what motivates women to switch 
methods in the postpartum period. This study could also investigate what dictates when women 
discontinue contraceptives in an effort to become pregnant again.  
 This study also builds a foundation for studies to test how short interpregnancy intervals 
affect pregnancy and birth outcomes among privately insured women. Future studies could 
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match the maternal insurance claims with those of infants and young children to determine how 
interpregnancy intervals are linked to outcomes such as pregnancy loss, infant birthweight, and 
gestational age at delivery. Finally, currently there is not literature on the economic implications 
impact of short interpregnancy intervals for insurance payers. Future analysis could build off this 
study and integrate infant health claims to understand the potential effects of postpartum 
contraceptive initiation on unintended pregnancies, preterm and low birthweight infants, and 
NICU admissions. 
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